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ABSTRACT 
THE INTERACTION OF HOMOSERINE LACTONES AND 
PARAOXONASE 2 MODULATES CELL DEATH SIGNALING AND 
CELL PROLIFERATION 
 
Aaron Mackallan Neely 
February 23rd, 2017 
Pseudomonas aeruginosa produces N-(3-oxododecanoyl)-homoserine lactone 
(C12) as a quorum-sensing molecule that functions to facilitate bacteria-bacteria 
communication.  C12 has also been reported to affect many aspects of human 
host cell physiology, including evoking cell death in various types of cells.  
However, the signaling pathway(s) leading to C12-triggerred cell death remains 
unclear.  To clarify cell death signaling induced by C12, we examined mouse 
embryonic fibroblasts (MEFs) deficient in one or more caspases.  Our data 
indicate that, unlike most apoptotic inducers, C12 evokes a novel form of 
apoptosis in cells, probably through the direct induction of mitochondrial 
membrane permeabilization.  Importantly, C12 induces apoptosis in human 
tumor cells and inhibits tumor growth in animals independent of both pro- and 
anti-apoptotic Bcl-2 proteins.  Previous studies indicate that C12 requires the
 vii 
lactonase/arylesterase paraoxonase 2 (PON2) to exert its cytotoxicity on MEFs.  
PON2 is known to function as a lactonase to cleave C12.  We found that PON2 
was overexpressed in tissues from non-small cell lung carcinoma (NSCLC) 
patients and oncogenically transformed human bronchia/tracheal epithelial 
(NHBE) cells.  Reducing PON2 expression in NSCLC cell lines as well as several 
non-transformed cell lines rendered them resistant to C12.  However, PON2 
expression is only important for the proliferation of NSCLC cells but not that of 
their untransformed counterparts, indicating that PON2 mediates apoptosis 
independently of its function to modulate cell proliferation.  Overall, our results 
reveal a unique mitochondrial apoptotic signaling pathway triggered by 
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CHAPTER I  
INTRODUCTION 
Tissue differentiation and homeostasis are tightly regulated by the BcL-2 
regulated cellular suicide program, apoptosis (1, 2). Many human tumor cells 
acquire resistance to conventional chemotherapeutic drugs that depend on BcL-2 
proteins. These neoplastic cells have been found to have an increased ratio of 
anti-apoptotic to pro-apoptotic Bcl-2 proteins. Thus, the discovery of novel drugs 
that are capable of overcoming apparent tumor cell BcL-2 protein dependent 
resistance to cell death is a major challenge.  A promising anti-tumor approach is 
the identification of small molecules (as well as their cellular targets) that 
preferentially trigger tumor cell apoptosis, independent of tumor cell Bcl-2 protein 
profile (3, 4).  While several candidate compounds have been identified, most if 
not all of these drugs could only induce apoptosis independent of either anti-
apoptotic or pro-apoptotic Bcl-2 proteins; but not both (4-6). Conversely, the 
quorum-sensing molecule N-(3-oxododecanoyl)-homoserine lactone (C12) 
preferentially induces transformed cell apoptosis in vitro and inhibits transplanted 
tumor growth in vivo independent of both anti- and pro-apoptotic Bcl-2 proteins, 
thereby making it an ideal candidate drug. Our preliminary data indicates that 
C12 triggers Bcl-2 protein-independent apoptosis, likely mediated by 
Paraoxonase 2 (Pon2). PON2 is known to function as a lactonase to cleave C12.  
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Previous studies indicate that C12 requires the lactonase / arylesterase PON2 to 
exert its cytotoxicity (7, 8) 
 
 1.1. Programmed cell death-Apoptosis    
The word Apoptosis derives from Greek origin meaning “dropping off or falling 
off,” and initially referred to the process by which leaves fell from trees or petals 
from flowers. Apoptosis is a biological phenomenon that consists of a 
programmed sequence of biochemical events that culminate in the selective 
elimination of damaged, infected and potentially neoplastic cells from the bodies 
of multicellular organisms (9, 10).  Apoptosis is one of the most ubiquitously 
employed mechanisms by which the body disposes of cell debris or damaged 
cells without eliciting localized inflammation; due to leakage of cellular 
contents(11). This mode of cell death is a vital component of normal tissue 
development, disease progression and maintenance of tissue homeostasis. 
Additionally, it serves as a means of defense against the development and 
advancement of cancer (12). The biochemical events that result in the 
occurrence of Apoptosis also elicit a large number of morphological changes in 
cells including cell shrinkage, blebbing of the membrane, condensation and 
fragmentation of nuclear material and the formation of apoptotic bodies. 
 
1.2. Regulation of apoptosis 
Apoptosis is under stringent genetic control and can be activated by stimuli from 
multiple sources. It is initiated in response to specific developmental signals or in 
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the presence of various stimuli including the reduction of essential growth factors, 
the activation of Tumor Necrosis Factor receptors (TNFR), DNA damage, loss of 
cellular attachment, decreases in the local concentration of tissue morphogens 
and major alterations in homeostatic state of the cell(13, 14). 
 Excess or limited apoptosis can disrupt tissue homeostasis of multicellular 
organisms. When apoptosis occurs more frequently than cell proliferation does, 
neurodegenerative disorders are exacerbated. Further to this, the dysregulation 
of apoptosis has been implicated in the ontogeny and progression of many 
disease states including many cancers and neurodegenerative disorders such as 
Alzheimer’s, Huntington’s and Parkinson’s diseases (15-17).  Conversely, 
insufficient apoptosis can precipitate cancer development and progression (18, 
19). Thus, tight regulation between apoptosis and cell proliferation is imperative 
for the viability of all multicellular organisms. 
 
1.3. Biological significance of apoptosis 
Apoptosis has long been recognized as a critical regulatory component of the 
development process. The role of apoptosis in development has been 
investigated and well established in three organisms: Nematodes 
(Caenorhabditis elegans), Fruit Flies (Drosophila melanogaster) and mouse (Mus 
musculus). Apoptosis has been found to drive hemaphroditic development during 
embryogenesis in C. elegans and promote the completion of development in D. 
melanogaster(20).  Studies have indicated that the inhibition of apoptosis elicits 
developmental impediments, disorders and/or death (12, 21). 
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In early mammalian development, apoptosis is instrumental in the formation of 
synapses between neurons in the brain and the spinal cord as it facilitates the 
removal of excess neuron cells (22).  Additionally, apoptosis assists in tissue 
remodeling, molding and shaping of the body and organs and the 
detailing/separation of extremities (fingers and toes) by the removal of excess 
tissues. Inhibition or insufficient apoptotic signaling elicits malformed limbs and 













Figure 1.1.  Apoptosis is required for proper development. (A) Cells between the 
digits undergo apoptosis to facilitate proper finger and toe formation. (B) 
Insufficient apoptosis elicits malformed digits that are joined by soft tissues 























Apoptosis is also vital in the removal of those cells that may have deleterious 
effects on the organism. These include cells that are capable of participating in 
an autoimmune response as well as virally infected; and thus cytotoxic, T cells 
(24).  Apoptosis facilitates the maintenance of tissue homeostasis. In the average 
adult, billions of cells die daily via apoptosis and are then replaced with new cells 
that originate from the body’s stem cell populations (25).  Apoptosis regulates the 
constant internal environment and normal tissue homeostasis. Under healthy and 
normal conditions, the rate of cell proliferation is approximately the same as the 
rate of apoptosis. This paradigm is essential for ensuring the viability of 
multicellular organisms. If this balance is disrupted, such that the occurrence of 
cell death is more frequent than that of cell replacement, the probability of the 
onset of neurodegenerative disorders is amplified. Moreover, inadequate 
apoptosis may elicit cancer development (26). 
 
1.4. The pathways of apoptosis 
Apoptosis typically occurs through one of three signaling pathways, namely the 
mitochondrial (intrinsic), the death receptor (extrinsic) and the mixed pathways.  
 
1.4.1. The intrinsic pathway of apoptosis 
Intracellular death signals are translocated to the mitochondria where they induce 
the mitochondria dependent intrinsic pathway of apoptosis. These signals 
activate the pro-apoptotic Bcl-2 proteins, which in turn lead to the formation of 
permeation channels on the outer mitochondrial membrane (OMM). These 
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permeation channels facilitate the release of apoptogenic proteins (Diablo/Smac 
and cytochrome c) from the mitochondrial inter-membrane space (IMS) into the 
cytosol.  Upon release into the cytosol, Diablo/Smac and cytochrome c induce a 
cascade of caspase reactions that culminate in the occurrence of apoptosis (27). 
Cytochrome c activates apoptotic protease factor 1 (apaf1), which promotes the 
transition of procaspases to their active caspase form.  Diablo/Smac promotes 
apoptosis through direct interaction with inhibitors of apoptosis proteins (IAPs), 



































Figure1.2. The intrinsic (mitochondrial) pathway of apoptosis. Apoptotic stimuli; 
such as DNA damage, elicits p53 activation. Activated p53 activates pro-
apoptotic Bcl-2 proteins which in turn forms permeation channels on the OMM. 
These permeation channels facilitate the transport of cytochrome C and 
Diablo/Smac into the cytosol. While in the cytosol, cytochrome C initiates a 
caspase cascade that culminates in the occurrence of apoptosis while 
Diablo/Smac interacts with IAPs impeding their ability to inhibit caspases thereby 



















1.4.2. The extrinsic pathway of apoptosis 
In contrast to the intrinsic apoptotic pathway, death signals for extrinsic apoptotic 
pathways are initiated from the outside of the cell. Induction of the extrinsic 
apoptotic pathways does not involve the mitochondria, involvement of the Bcl-2 
protein family or the release of cytochrome c forms the mitochondrial IMS to the 
cytosol.  In this pathway, specific death ligands such as tumor necrosis factor 
(TNF), Fas Ligand (FasL) or TNF-related apoptosis-inducing ligand (TRAIL) 
binds to their respective specific transmembrane death receptors including FAS, 
tumor necrosis factor receptor 1 (TNFR1), p75, DR4(30). 
 
The binding of death ligands to their respective specific death receptor promotes 
the collection and recruitment of the adaptor protein Fas-associated death 
domain (FADD) and the inactive forms of the initiator caspases 8 and 10 (pro-
caspases 8 and 10), thus allowing for the formation of the death-inducing 
signaling complex (DISC).  The DISC transports the procaspase molecules in 
close proximity, thereby ensuring access for their autocatalysis and eventual 
release into the cytosol (31-35).  Caspase 8 or 10 will then activate the effector 
caspases 3/7 in a cascade precipitated by caspase-mediated reactions that will 
culminate in the occurrence of apoptosis. 
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Figure 1.3. The extrinsic (death receptor) pathway of apoptosis. Extrinsic 
apoptotic signaling is generated extracellularly with the binding of death ligands 
to specific transmembrane death receptors.  Activation of death receptors elicit 
clustering and recruitment of the adaptor molecule FADD, procaspase 8, 10 
resulting in the formation of the DISC. DISC formation activates caspase 8, 10. 
Caspase 8, 10 then activates caspase 3/6/7 and leads to apoptosis.  The figure 












1.4.3.  The mixed pathway of apoptosis 
There exist certain instances where the induction of apoptotic signaling cascades 
from external sources can also elicit the activation of both intrinsic and extrinsic 
apoptotic pathways. This phenomenon is known as the mixed apoptotic pathway 
and entails death stimuli that are generated extracellularly causing the activation 
of pro caspase 8, pro caspase 10, and formation of the DISC; in the same 
manner as observed in the extrinsic apoptotic pathway.  The DISC formation will 
ultimately lead to autocatalysis and the eventual activation of caspase 8 and 10 
(31-35). When caspase 8 is activated, it can enter one of two routes: (i) it can 
activate the effector caspases 3, 6 and 7, thereby eliciting apoptosis via the 
extrinsic pathway or (ii) it can enter the intrinsic apoptotic pathway via interaction 
with the Bcl-2 protein family. In this instance, caspase 8 will cleave the inactive 
pro-apoptotic BH3-only protein “Bid” into its truncated and active form tBid. The 
tBid then activates the Bcl-2 proteins Bax and Bak at the OMM. Bak and Bax 
then undergo conformational changes as well as oligomerization thereby yielding 
the formation of permeation pores on the OMM. Permeation pore formation elicits 
the release of cytochrome c and Diablo/Smac from the mitochondrial IMS into the 
cytosol. Once in the cytosol, cytochrome c and Diablo/Smac exert their pro-
apoptotic effects in the same fashion as they do in the intrinsic apoptotic pathway 

















Figure 1.4. The mixed pathway of apoptosis. Extracellular stimuli lead to the 
formation of DISC and the subsequent activation of caspases 8 and 10. Activated 
caspase 8 and 10 can cleave effector caspases to elicit cell death via the 
extrinsic pathway or can enter the intrinsic pathway by interacting with Bcl-2 
proteins. Caspase 8 converts Bid into tBid, which then interacts with Bax/Bak 
inducing their oligomerization and formation of permeation pores on the OMM, 
which facilitates the transport of apoptogenic proteins such as cytochrome c and 



















1.5.  Capases 
The caspases and the Bcl-2 protein family are primary regulators of Apoptosis. 
The caspases are a group of cysteine proteases, which cleave proteins at sites 
that are proximal to aspartic acid residues(37).  Caspase activation is typically 
considered the molecular hallmark of apoptosis(38). Caspases exist in their 
inactive forms (pro caspase), and become activated during apoptosis by pro-
apoptotic proteins(39).   
 
While 12 caspases have been identified to date, not all play a role in the 
regulation of apoptosis. For instance, caspase 1 is instrumental in the regulation 
of biological processes that are unrelated to cell death including red blood cell 
and skeletal muscle myoblast maturation.  In contrast, caspase 14 is critical in 
skin cell development(40). 
 
There are two classes of caspases involved in apoptosis namely the initiator 
(apical) and the effector (executioner) caspases. The initiator caspases include 
caspases 2, 8, 9 and 10 and are activated in response to upstream apoptotic 
stimuli. The initiator caspases cleave and process the effector caspases 3, 6 and 
7. Upon activation, the effector caspases trigger cell death by degrading critical 





1.6.  The Bcl-2 proteins 
The Bcl-2 family of proteins is a major regulator of the intrinsic pathway of 
apoptosis. Their names derived from B-cell lymphoma/leukemia 2, and are the 
second member of a collection of proteins initially discovered during 
chromosomal translocations involving chromosomes 14 and 18 in human 
follicular lymphomas (41). There are approximately 20 different members of the 
Bcl-2 protein family. Bcl-2 protein family members all share one to four 
homologous Bcl-2 homology (BH) domains that are important for homo and 
hetero-dimeric interactions among different family members. Bcl-2 proteins are 
either pro-apoptotic or anti-apoptotic (1, 2, 13) depending on the amount of BH 
domains and their ability to regulate apoptosis(42). 
 
Pro-apoptotic Bcl-2 proteins are important for the initiation and stimulation of the 
intrinsic apoptotic pathway. These proteins are divided into two structurally and 
functionally distinct categories: multi-domain and BH3-only Bcl-2 proteins(43).  
Multi-domain pro-apoptotic Bcl-2 proteins Bak, Bax and Bok share three BH 
domains (BH1-BH3). They are responsible for the formation of permeation 
channels on the OMM that disturbs mitochondrial membrane integrity during 
apoptosis.  This facilitates the release of apoptogenic proteins from the 
mitochondria into the cytosol (44). Bak and Bax are ubiquitously expressed in all 
tissues while Bok is present only in reproductive cells (44). Bax and Bak are 
localized in different subcellular compartments of healthy cells. In the presence of 
death stimuli Bax undergoes conformational changes at both the amino- and 
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carboxyl- termini eliciting its translocation from the cytosol to the OMM and the 
eventual formation of large oligomeric complexes.  Bak is localized solely in the 
mitochondria and upon apoptotic stimuli, will undergo conformational changes 
elicit the formation of oligomeric complexes (45, 46).  The oligomeric form of Bax 
and Bak form permeation pores on the OMM (47). These permeation channels 
mediate the release of pro-apoptotic proteins cytochrome c and Smac/Diablo 
from the IMS of the mitochondria to the cytosol where they exert their effects. 
 
1.7.  Other cell death modalities - Autophagy and Necrosis  
Autophagy is a tightly regulated, ordered cell death process. It is self-degradative 
and essential for the maintenance of the balance of sources of energy at critical 
stages of development as well as in response to nutrient deprivation(48).  
Autophagy is also responsible for the removal of damaged organelles, misfolded 
and aggregated proteins(49) and the elimination of intracellular pathogens(50). 
The deregulation of autophagy has been implicated in non-apoptotic cell death. 
Autophagy can be selective or non-selective in the removal of specific 
organelles, ribosomes and protein aggregates(51). Furthermore, autophagy 
promotes cellular senescence and cell surface antigen presentation. It protects 
against genomic instability and is critical in the prevention of necrosis(50). Thus, 
autophagy has a key role in the prevention of diseases including cancer, 
neurodegeneration, liver diseases, autoimmune diseases, cardiomyopathy and 
infections. Increased endocytosis, vacuolation, membrane blebbing and nuclear 
condensation are all characteristic morphological hallmarks of autophagy. This 
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type of cell death is categorized as a defensive reaction that can elicit cell death 
or cell survival(50).  
 
Another modality of cell death is necrosis.  Necrosis is the irreversible loss of 
plasma membrane integrity(52). It is a form of cell injury that results in the 
premature death of cells in living tissue by autolysis. This type of cell death lacks 
the features of apoptosis and autophagy, and typically is considered uncontrolled 
(52, 53). Necrosis is typically connected to immoderate cell loss in human 
pathologies and can lead to local inflammation (54-56), thought to occur through 
the liberation of factors from dead cells that alert the innate immune system (53, 
54, 57).  Necrosis is signaled by irreversible cytoplasmic alterations 
(condensation, fragmentation and loss of structure) and nuclear changes 
(pyknosis, karyolysis and karyorhexis) (52, 53). Infection, toxins and trauma can 
result in the unregulated digestion of cell components leading to necrosis. 
 
1.8.  N-(3-oxododecanoyl)-homoserine lactone (C12) 
The gram-negative opportunistic bacterium Pseudomonas aeruginosa produces 
N-(3-oxododecanoyl)-homoserine lactone (C12) as a quorum-sensing molecule 
used to facilitate bacteria-bacteria communication (6).  Quorum sensing is a 
bacterial communication system that releases and detects small diffusible 
autoinducers (7, 58). This system is responsible for the regulation of bacterial 
gene expression in response to changes in cell population density(58). Gram 
positive and gram-negative bacteria employ quorum-sensing communication to 
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regulate a variety of physiological functions including: symbiosis, antibiotic 
production, conjugation, motility and biofilm formation(58). Mounting data has 
shown that C12 is involved in the regulation of bacterial virulence genes and also 
interacts with eukaryotic cells (59, 60).   As a small, lipid-soluble and diffusible 
molecule, C12 readily enters cells of multiple tissues in the lungs of cystic fibrosis 
patients including fibroblasts, epithelial cells, leukocytes, and endothelial cells 
(8).  Additionally C12 alters many aspects of eukaryotic cell physiology including 
the inhibition of the secretion of proinflammatory cytokines (61-64), activation of 
p53, and inhibition of events commonly associated with cell death (65-68). C12 
has been shown to induce apoptosis in multiple types of cancer cells (66, 69-71). 
C12 induces apoptosis by inhibiting phosphatidylinositide3-kinases, arresting 
Akt/PKB pathway and attenuating STAT3 activity in breast carcinoma cells (7, 
66).  In pancreatic carcinoma cells, C12 induces apoptotic signaling and inhibits 
cell migration (7, 70). In colorectal cancer cells, C12 reduces the expression of 
thymidylate synthase while enhancing the activity of otherwise conventional 
chemotherapeutic agents including 5-fluorouracil (5-FU) (69). 
 
 Comparative SAR analysis has indicated that long acyl side chains with a 3-oxo 
substitution are essential for C12’s anti-cancer effect (69). However, the exact 
signaling pathway(s) leading to C12-triggered cell death remains unclear.   Our 
preliminary studies indicate that C12-triggered tumor cell apoptosis occurs by 
selectively activating the mitochondria-specific intrinsic pathway through a novel 
mechanism that is independent of activities of both anti- and pro-apoptotic Bcl-2 
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proteins in human tumor cells.  We also find that C12 induces apoptosis 
preferentially in oncogenically transformed but not in non-transformed human 
bronchial epithelial cells.  Importantly, we discovered that C12 cytotoxicity is 
mediated through the lactonase activity of paraoxonase 2 (PON2).   
 
1.9.  Paraoxonase 2 (PON2) 
PON2 is a ubiquitously expressed mammalian protein with anti-oxidant 
properties and lactonase/arylesterase activities (72, 73). PON2 belongs to the 
Paraoxonase family of proteins and rapidly hydrolyzes C12 to C12-
acid(carboxylic acid), which becomes trapped and accumulates within human 
bronchial epithelial cells, particularly in mitochondria (74-77).  PON2 is 
upregulated in many types of cancer; including lung cancer, enabling cancer cells 
to resist conventional therapeutic drugs (78, 79). PON2 and PON3 appear to 
promote chemotherapeutic resistance and cell survival. 
 PON2 expression also prevents oxidation and inflammation, but the detailed 
mechanisms remain unclear.  This membrane-bound protein’s expression is 
markedly elevated in several human non-small cell lung carcinoma (NSCLC) cell 
lines.  Mutations in the Pon2 gene may be associated with vascular disease and 
a number of phenotypes related to diabetes. 
 
It has been accepted that oxidative stress derived from the mitochondria, plays 
an integral role in apoptosis thereby eliciting premature aging and cancer. Recent 
studies have suggested that various types of cancer take advantage of protection 
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derived from increased expression of antioxidant paraoxonase proteins. 
Microarray studies have suggested an overexpression of PON2 in solid tumors 
such as hepatocellular carcinomas and prostate carcinomas. Other studies have 
identified PON2 as a member of a small category of upregulated genes that were 
correlative with poor prognosis. Studies have shown that PON2 levels are 
increased in some tumors at the protein level. Investigators observed moderate 
PON2 overexpression in pancreas, liver, kidney and lung tumors and more than 
10-fold upregulation of PON2 in thymus tumors and non-Hodgkins lymphomas. 
cDNA arrays have shown that PON2 is ~2-4-fold overexpressed in urinary 
bladder tumors, liver and kidney tissues in comparison to normal tissues.  
 
1.10.  Hypothesis and Significance of the project 
1.10.1.  Hypothesis and Specific Aims 
N-(3-oxododecanoyl)-homoserine lactone (C12) is produced by Pseudomonas 
aeruginosa to function as a quorum-sensing molecule for bacteria-bacteria 
communication.  As a small, lipid-soluble, diffusible molecule, C12 readily enters 
various types of cells in the lungs of infected patients, including epithelial cells, 
endothelial cells, fibroblasts and leukocytes, and its concentration is believed to 
reach high micromolar levels in or adjacent to biofilms formed in the lung 
airways.  C12 has been reported to alter many aspects of human airway 
epithelial cell physiology, including inhibition of proinflammatory cytokine 
secretion and activation of events commonly linked with apoptotic cell death.  
However, the signaling pathway of C12-triggered apoptosis is still unclear.   
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Our overall hypothesis is that C12 triggers a novel form of apoptosis in 
mammalian cells.   We proposed the following specific aims to investigate our 
hypothesis. 
 
Specific aim 1. Investigate the detailed molecular mechanism of apoptosis 
induced by C12.  
C12 is known to evoke apoptotic cell death in mammalian cells.  However, the 
signaling pathway(s) leading to C12-triggered cell death is (are) still not 
completely known.  Particularly, the potential interplay between extrinsic and 
intrinsic pathways and “initiator” vs “effector” caspases in C12-activated apoptotic 
signaling remains unclear.  To clarify cell death signaling induced by C12, we 
systematically examined mouse embryonic fibroblasts (MEFs) deficient in 
“initiator” caspases or “effector” caspases.   
 
Specific aim 2.  Explore the mechanism of how C12 induces tumor cell apoptosis 
and inhibits tumor growth.  
C12 has been reported to induce apoptosis in various types of tumor cells.  
However, the detailed molecular mechanism of C12-triggerred tumor cell 
apoptosis is still unclear. In addition, it is completely unknown whether C12 
possesses any potential therapeutic effects in vivo.  To gain insights into the 
mechanism of C12-evoked tumor cell apoptosis, we evaluated the cytotoxic 
effects of C12 on tumor cells in vitro, the inhibitory effects of C12 on tumor 
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growth in vivo.  In addition, the role of pro- and anti-apoptotic Bcl-2 in C12-
induced tumor cell apoptosis was systematically examined.  
 
Specific aim 3. Investigate the prospective role of PON2 in C12 cytotoxicity and 
elucidate the mechanism of PON2 regulation of lung tumor cell proliferation. 
In nontransformed fibroblast cells, overexpression of Paraoxonase 2 (PON2) 
promotes cytotoxicity of C12, but the role of endogenous PON2 in C12-evoked 
apoptotic signaling was unclear.  To further investigate the mechanism of C12-
triggered apoptosis in tumor cells, we studied the involvement of endogenous 
PON2 in C12 cytotoxicity by stably reducing PON2 expression in human non-
small cell lung cancer (NSCLC) cells.  We also investigated the role of PON2 in 
proliferation of NSCLC cells. 
 
1.10.2.  Significance of Project  
The data acquired from this project elucidate a novel form of apoptosis induced 
by C12 in tumor cells through inducing mitochondrial membrane permeabilization 
independent of both pro- and anti-apoptotic Bcl-2 proteins. The distinctive pro-
apoptotic feature of C12 has not been observed in any other apoptosis 
paradigms, which might be attributed to the ability of C12 or its metabolite(s) to 
directly permeabilize mitochondria (within minutes) by forming permeation 
channels without the involvement of Bcl-2 proteins. 
Furthermore, our studies show that expression of PON2 is increased in NSCLC 
patient tissues, which renders NSCLC cells sensitive to C12 but resistant to 
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conventional therapeutic drugs.  Importantly, PON2 expression in NSCLC cells is 
essential for their rapid proliferation.  Therefore, C12 or compounds derived from 
C12 could trigger rapid and Bcl-2 protein-independent apoptosis in PON2-
overespressing NSCLC tumors that are resistant to traditional therapeutic drugs, 
whereas normal tissues are spared due to their lower PON2 expression.  Overall, 
C12 or C12 derivatives may be developed into useful therapies for NSCLC 
tumors resistant to classical anti-cancer drugs due to dysregulated Bcl-2 protein 














N-(3-OXO-ACYL)-HOMOSERINE LACTONE INDUCES APOPTOSIS 
EXCLUSIVELY THROUGH A MITOCHONDRIAL PATHWAY 
2.1. INTRODUCTION 
The gram-negative aerobic bacterium Pseudomonas aeruginosa is ubiquitously 
present in soil, water, and vegetation, and is infectious to patients with cystic 
fibrosis, cancer, burns or compromised immune systems (80).  Pseudomonas 
aeruginosa often infects the lungs of patients with cystic fibrosis, where they 
form biofilms and eventually become antibiotic resistant (81).  Like many other 
bacteria, Pseudomonas aeruginosa controls these virulence properties by 
communicating with each other through quorum-sensing, a system of response 
and stimuli by which the bacteria constitutively generates, releases, detects and 
responds to small diffusible autoinducers (58).  The quorum-sensing molecule 
N-(3-oxododecanoyl)-L-homoserine lactone (C12) is produced by 
Pseudomonas aeruginosa and regulates bacterial LasI/rhlI and lasR/rhlR gene 
networks in addition to influencing bacterial intercellular communication (82, 
83). As a small, lipid-soluble and diffusible molecule, C12 readily enters various 
types of cells in the lungs of infected patients, including epithelial cells, 
endothelial cells, fibroblasts and leukocytes (6, 59, 84), where its concentration 
is believed to reach high micromolar levels in or adjacent to biofilms formed in 
the lung airways (65, 85, 86).  C12 has been reported to alter many aspects of 
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human airway epithelial cell physiology, including inhibition of proinflammatory 
cytokine secretion and activation of events commonly linked with apoptotic cell 
death; including plasma membrane blebbing, cell shrinkage, and nuclear 
condensation and fragmentation, caspase activation and mitochondrial 
membrane permeabilization (65, 66, 69, 87, 88).  
 
Upon C12 exposure, the activation of diverse signaling pathways associated 
with apoptosis is observed in different mammalian cells.  In breast carcinoma 
cells, C12 partially inhibits the Akt/PKB pathway, and the JAK/STAT pathway 
likely mediates pro-apoptotic activities of C12 (66).  Similarly, C12 suppresses 
Akt activation by blocking Akt phosphorylation in undifferentiated intestinal 
epithelial cells, and overexpression of constitutively active Akt is capable of 
partially reducing C12 cytotoxicity (89).   
 
Signaling from the endoplasmic reticulum (ER) has also been implicated in 
apoptosis caused by C12.  ER stress-responsive proteins inositol-requiring 
enzyme 1 (IRE1 and X-Box Binding Protein 1 (XBP1) are required for C12-
induced killing of mouse embryonic fibroblasts (MEF) (90).  Furthermore, 
apoptosis-like morphological changes in the ER and mitochondria are observed 
in bone marrow-derived macrophages upon C12 treatment (91), and 
phosphorylation of mitogen-activated protein kinase p38 and eukaryotic 
translation initiation factor 2 (eIF2) are two biochemical markers indicative of 
cellular responses to C12 (91). 
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Caspase activation is commonly observed in C12-exposed cells.  Caspases are 
classified into two major categories: “initiator” caspases and “effector" caspases 
(92), both of which are activated by C12.  Serving as a marker for C12-triggered 
apoptosis, activation of the effector caspase-3 has been detected in airway 
epithelial cells (65), fibroblasts (68, 93), intestinal epithelial cells (89), breast 
carcinoma cells (66), lymphoma cells (94), lung carcinoma cells (7), colorectal 
carcinoma cells (95), and leukocytes (91, 96, 97).  Activation of the “initiator” 
caspases caspase-8 (65, 94, 97, 98) and caspase-9 (65, 91) has also been 
reported.  These data have suggested that both the extrinsic pathway initiated 
at the plasma membrane and the intrinsic pathway initiated in mitochondria may 
be activated.   
 
However, the potential interplay between extrinsic and intrinsic pathways and 
“initiator” vs “effector” caspases in C12-activated apoptotic signaling remain 
unclear.  In this aim, MEFs deficient in one or more caspases were investigated 
to elucidate the cell death signaling induced by C12.  Our data indicate that C12 
selectively triggers an apoptotic-signaling pathway in which C12 appears to act 







2.2.  MATERIALS AND METHODS 
2.2.1.  Reagents   
N-(3-oxododecanoyl)-homoserine lactone (C12), desferrioxamine (DFO), 
hydrogen peroxide (H2O2), cycloheximide, etoposide and actinomycin D were 
purchased from Sigma (St. Louis, MO).  Propidium iodide (PI) was obtained 
from Thermo (Waltham, MA).  Recombinant human TNF-α was purchased from 
Peprotech (Rocky Hill, NJ).  The Smac mimetic TL-32711 was purchased from 
Active Biochem (Maplewood, NJ).  Unless otherwise stated, all reagents were 
dissolved in dimethyl sulfoxide (DMSO).  Dulbecco’s Modified Eagle’s Medium 
(DMEM), penicillin/streptomycin, trypsin, and L-glutamine were obtained from 
Mediatech (Manassas, VA), and fetal bovine serum (FBS) was purchased from 
Gemini (Broderick, CA). Caspase-Glo assay 3/7 kit was purchased from 
Promega (Madison, WI).  Antibodies (Abs) used for western blot analysis were 
anti-β-actin mAb (Sigma), anti-full-length-caspase-3 pAb; anti-full-length-
caspase-7 pAb; anti- full-length-caspase-8 pAb; anti- full-length-caspase-9 pAb; 
anti-cleaved-caspase-3 pAb; anti-cleaved-caspase-7 pAb; anti-PARP pAb (Cell 
signaling; Danvers, MA),), anti-cytochrome c mAb for western blot (Santa Cruz; 
Dallas, TX), anti-cytochrome c mAb for immunofluorescence staining (BD 
Transduction Laboratory; San Jose, CA), anti-Tom40 pAb (Santa Cruz), anti-
Tom20 pAb (a gift from Dr. Brian Wattenberg), peroxidase-conjugated goat anti-




2.2.2.  Cell lines and cell culture  
Immortalized mouse embryonic fibroblasts (MEFs) deficient in the expression of 
caspase-8 and their wild-type counterparts were provided by Professor David 
Vaux (Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 
Australia).  MEFs lacking caspase-9 and their wild-type counterparts were 
obtained from Professor Jerry Adams (Walter and Eliza Hall Institute of Medical 
Research).  MEFs lacking caspase-3, caspase-7, caspase-3 and caspase-7, or 
their wild-type counterparts were obtained from Professor Richard Flavell (Yale 
University).  Human colorectal carcinoma HCT116 and human pancreatic 
carcinoma Panc-1 were purchased from ATCC (Manassas, VA).  To generate 
HCT116 and Panc-1 cells with reduced caspase-8 expression or vector control, 
cells were first infected by caspase-8 shRNA lentiviral particles or control 
shRNA lentiviral particles with 10 µg/ml polybrene (Santa Cruz).  Stable cells 
were obtained by culturing cells in the medium with 5 g/ml puromycin.   All of 
the cell lines were grown and maintained in DMEM supplemented with 10% 
FBS,100 units/ml penicillin, and 100 µg/ml streptomycin.  Cells were all cultured 
in a 5% CO2 humidified incubator at 37oC. 
 
2.2.3.  Cell Viability/Death Assays 
MEF cell lines were plated in a 48-well tissue culture plate with 20,000 cells in 
each well and cultured for 24 hours.  Following treatment with different 
concentrations of C12, cells were harvested in the presence of 1.0 µg/ml 
propidium iodide (PI).  Cell viability was measured by PI exclusion using flow 
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cytometry (FACScalibur, Beckon Dickinson; San Jose, CA). The percentage of 
cell death was determined as100 minus the cell viability measurement. 
 
2.2.4.  Caspase-3/7 activity 
Caspase-3/7 activities were measured using a Caspase-Glo assay kit 
(Promega, Madison, WI)(59).  In this assay, the proluminescent substrate 
containing the amino acid sequence Asp-Glu-Val-Asp (DEVD) is cleaved by 
activated caspase-3/7, resulting in the release of a luciferase substrate 
(aminoluciferin) and the production of luminescent signal.  24 hours before the 
treatment, cells were plated in white-walled 96-well plates.  At the indicated time 
points following treatment with various agents, cells were mixed with CellTiter-
Glo reagent, and luminescence was quantified by a Gemini EM microplate 
spectrofluorometer (Molecular Devices; Sunnyvale, CA) according to the 
manufacturer’s protocol.  Data were presented as relative luminescence units 
(RLUs). 
 
2.2.5.  Western blot analysis 
Equal amounts of proteins (30 µg) were separated on a 4-12% Bis-Tris gel (Bio-
Rad; Hercules, CA) and transferred onto PVDF membrane (Millipore; Billerica, 
MA). The membrane was incubated with appropriate primary or secondary 
antibodies either overnight at 4oC or at room temperature for 3 hours in 1X 
phosphate-buffered saline (PBS) containing 5% (w/v) nonfat dry milk (Bio-Rad) 
and 0.2% (v/v) Tween 20. Protein levels were detected using the enhanced 
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chemiluminescent detection system (Pierce; Rockford, IL) as described 
previously (99). 
 
2.2.6.  Measuring Δmito using imaging microscopy of JC1 
For imaging experiments to measure mitochondrial membrane potential 
(Δmito), cells were incubated with growth media containing the Δmito probe 
JC1 (10 μM) for 10 minutes at room temperature, and then washed three times 
with Ringer’s solution to remove the extra dye.  JC1-loaded cells were placed 
onto a chamber on the stage of a Nikon Diaphot inverted microscope.  Cells 
were maintained at room temperature during the course of the experiments.  
Treatments were made by diluting stock solutions into Ringer’s solution at the 
concentrations stated in the text.  Fluorescence imaging evaluation of Δmito 
was carried out using equipment and methods that have been reported 
previously (93, 95).  Briefly, a Nikon Diaphot inverted microscope with a Fluor 
20 X objective (0.75 numerical aperture) was used.  A charge coupled device 
camera acquired JC-1 emission images (green: 510–540 nm; red: 580–620 nm) 
during excitation at 490 +/- 5 nm using filter wheels (Lambda-10, Sutter 
Instruments, Novato, CA).  Axon Imaging Workbench 5.1 (Axon Instruments, 
Foster City, CA) controlled filters and collection of data.  Images were corrected 
for background using regions without cells.  The data were calculated with JC1 
fluorescence ratios normalized to minimal JC1 ratios obtained at the beginning 
of the experiment and maximal JC1 ratios acquired following 5 μM FCCP 
treatment.  Normalized JC1 Ratio = (Ratio at a given time - minimal Ratio) / 
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(maximal ratio - minimal Ratio) * 100%. Normalized JC1 ratios at plateau 
(before FCCP treatment) from at least three different experiments have been 
averaged for summary graphs. 
 
2.2.7.  Immunofluorescence microscopy 
MEFs plated onto cover glasses 24 hours earlier were rinsed with Ringer’s 
solution and incubated for 4 hours with either vehicle (DMSO) or 50 µM C12 in 
Ringer’s solution. The immunofluorescence staining of cytochrome c and 
Tom20 were carried out as described previously (95).  Images were captured 
using a Nikon Eclipse Ti confocal microscope (Nikon; Melville, NY) equipped 
with a PlanApo 60x, 1.42 NA oil immersion objective.  To minimize variability for 
quantitative assessment, the same microscope settings were used across 
vehicle control and C12-treated samples for three individual experiments.  Four 
to nine fields of view were captured to acquire a sample size of at least 100 
cells for each individual experiment.  Intracellular distribution of cytochrome c 
and TOM20 was analyzed using ImageJ (NIH).  Cytochrome c release from 
mitochondria was quantified by determining the standard deviation (SD) of the 
mean pixel intensity of cytochrome c of each cell – this is named as the 
punctate/diffuse index (100-102).  Briefly, when cytochrome c is highly localized 
within mitochondria, it will display a punctate distribution pattern, leading to high 
SD of the average pixel intensity, but when cytochrome c is distributed 
throughout the cell, the SD will be low.  Therefore, a decrease in the SD 
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(punctate/diffuse index) is an index of cytochrome c redistribution from 
mitochondria to the cytosol.  
2.2.8.  Mitochondrial morphology 
To image mitochondrial morphology and membrane potential using confocal 
microscopy, cells were transfected with mitochondrial matrix-targeted GFP 
plasmid (Clontech; Madison, WI) using an Amaxa nucleofector device (Lonza; 
Allendale, NJ), seeded onto 35 mm glass coverslips and placed in a tissue 
culture incubator. After 16-24 hours coverslips were mounted in a recording 
chamber positioned on the stage of an inverted microscope (IX71; Olympus 
America Inc., Center Valley, PA). Cells were visualized using a PlanApo 60x, 
1.42 NA oil immersion objective and confocal time series images acquired using 
a VT-Infinity 3 (VisiTech International; Sunderland, UK). The chamber was 
perfused with Hank’s Balanced Salt Solution containing 20 nM mitochondrial 
membrane potential probe tetramethylrhodamine, ethyl ester (TMRE) at room 
temperature. After a 15 minute equilibration period, GFP and TMRE were 
alternately excited using the 488 and 568 nm lines respectively of a Krypon-
Argon laser. The emitted fluorescence was filtered using a dual bandpass filter 
set (VisiTech International) and collected and using HCImage software 
(Hamamatsu Corporation; Sewickley, PA). Mitochondrial morphology was 
analyzed using ImageJ to determine the mean area/perimeter ratio and inverse 
circularity as the measurement of interconnectivity and elongation respectively, 
as described previously. 
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2.2.9.  Detection of the release of cytochrome c from mitochondria  
Mitochondria were purified from MEFs as described previously (25). Isolated 
mitochondria were resuspended in buffer containing 12 mM HEPES (pH 7.5), 
1.7 mM Tris-HCl (pH 7.5), 100 mM KCl, 140 mM mannitol, 23 mM sucrose, 2 
mM KH2PO4, 1 mM MgCl2, 0.67 mM EGTA, and 0.6 mM EDTA supplemented 
with protease inhibitors (Complete; Roche Diagnostics, Indianapolis, IN). After 
one hour incubation with C12 at 30°C, mitochondrial vesicles were centrifuged 
at 10,000×g for 10 min and then dissolved in 1×SDS-PAGE loading buffer. 
Proteins in the supernatant and pellet fractions were detected by Western 
blotting.  
 
2.2.10.  Statistical analysis 
All experiments were performed in triplicate at least three times. Results are 
presented as mean ± standard deviation. Statistical analysis was performed 










2.3.  RESULTS 
2.3.1.  Apoptosis is the major form of cell death caused by C12. 
In multicellular organisms, cell death is a highly heterogeneous process in 
which several distinct, in some cases partially overlapping, cell signaling 
cascades can be activated (103).  Although C12’s ability to trigger the events 
commonly linked to apoptosis has been reported (65, 66, 90, 93, 96), it is 
unclear whether other cell death signaling is also involved.  Caspase-3 and 
caspase-7 are two highly related “effector” caspases, and mouse embryonic 
fibroblasts (MEFs) deficient in expression of both caspases are markedly 
resistant to both mitochondrial and death receptor-mediated apoptosis (104).  
To further characterize C12-induced signaling leading to cell death, we first 
investigated whether caspase-3 and caspase-7 were essential to mediate 
cytotoxic effects of C12.  Cytotoxicity of C12 was examined in MEFs lacking 
caspase-3 (caspase-3-KO), caspase-7 (caspase-7-KO), or both (caspase-3/7-
DKO) as well as their wild-type (WT) counterparts (Figure 2.1A).  C12 induced 
significant cell death in WT, caspase-3-KO and caspase-7-KO MEFs, whereas 
caspase-3/7-DKO MEFs were completely resistant to C12 exposure (Figure 
2.1B).  Moreover, less cell death was detected in caspase-3-KO or caspase-7-
KO MEFs than their wild-type counterparts (Figure 2.1B).  These data indicate 
that both caspase-3 and caspase-7 are involved in apoptosis initiated by C12; 
caspase-3 appeared to play a more prominent role than caspase-7.  
Importantly, cleavage of caspase-3 and caspase-7, one of the hallmarks of 
apoptosis, was detected in WT MEFs treated with C12 (Figure 2.1C).  
Furthermore, a known substrate of caspase-3 and caspase-7 PARP was also 
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cleaved in WT MEFs upon C12 exposure, but not in their caspase-3/7-DKO 
counterparts.  Overall, the essential role of caspase-3 and caspase-7 indicates 














Figure 2.1. Caspase-3 and caspase-7 are required for C12-induced cell death.  
(A) The expression of caspase-3 and caspase-7 in the indicated MEFs was 
examined by western blots. The molecular weight markers were labeled on the 
left (kD).  (B) MEFs were treated with C12 for 48 hours, and cell viability was 
measured by propidium iodide exclusion.  The data are presented as means ± 
standard deviations of three independent experiments.  Asterisks indicate P < 
0.01(*); Student's unpaired t test. ns, no significance.  (C) Activation of caspase-
3 and caspase-7 was determined by western blot.  Whole cell extracts of MEFs 
were acquired following 16 hour-treatment of C12.  The molecular weight 















2.3.2.  C12-induced MOMP is independent of caspase-3 and caspase-7. 
Mitochondrial outer membrane permeabilization (MOMP) has been recognized 
to be a “no-return” step in both intrinsic and extrinsic apoptotic pathways (105, 
106).  To further explore C12-initiated apoptotic signaling, we studied the 
involvement of caspase-3 and caspase-7 in two key events of MOMP: 
depolarization of mitochondrial membrane potential (∆mito) and release of 
cytochrome c from mitochondria into the cytosol.  Depolarization of Δmito was 
evaluated by determining the changes in fluorescence with the voltage-
dependent dye JC1 being released from mitochondria into the cytosol and 
nucleus.  Within minutes of C12 exposure, mitochondrial Δmito in WT MEFs 
became almost completely depolarized to a level close to the complete 
depolarization induced by the ionophore FCCP (Figure 2.2A), consistent with 
studies in other cell types (65, 95, 98).  Importantly, C12 triggered similar 
depolarization of Δmito in both WT and caspase-3/7-DKO MEFs (Figure 2.2B), 
















Figure 2.2.  Caspase-3 and caspase-7 are not required for mitochondrial     
depolarization induced by C12.   
(A) MEFs from WT and caspase-3/7-DKO mice were loaded with the 
mitochondrial potential dye JC-1, and fluorescence was measured using 
imaging microscopy during sequential treatment with 50 M C12 and 10 M 
FCCP.  Typical results from three independent experiments are shown.  (B) 
Addition of C12 caused equivalent depolarization of mitochondrial potential in 
WT and caspase-3/7-DKO MEFs.  All data are shown as means ± standard 















2.3.3.  C12-induced MOMP occurs independent and upstream of caspase-3/7 
activation. 
Immunofluorescence studies were used to evaluate C12-evoked redistribution 
of cytochrome c from mitochondria to the cytosol and nuclei.  As shown in 
representative images of both WT and caspase-3/7-DKO MEFs under control 
conditions, cytochrome c and the mitochondrial outer membrane protein Tom20 
exhibited overlapping punctate and perinuclear distribution in cells that is typical 
of mitochondrial morphology (Figure 2.3A).  In addition, nuclei displayed 
characteristic oval shape with smooth boundaries that largely excluded 
cytochrome c and Tom20.  Upon C12 treatment, distribution of cytochrome c 
was diffuse in the cytosol and nuclei in both WT and caspase-3/7-DKO MEFs, 
whereas Tom20 maintained its characteristic mitochondrial distribution, 
demonstrating that mitochondria in WT and caspase-3/7-DKO MEFs were 
permeabilized with cytochrome c released into the cytosol and diffused into the 
nuclei.  The redistribution of cytochrome c was quantitated by calculating the 
punctate/diffuse index.  These quantitative measurements showed that C12 
caused equivalent cytochrome c release in WT and caspase-3/7-DKO MEFs 
(Figure 2.3B), while Tom20 was still localized in mitochondria in the presence of 
C12 (Figure 2.3C).  Overall, these results provide more evidence that C12 










Figure 2.3.  C12-induced MOMP occurs upstream of caspase-3/7 activation.  
(A) Representative confocal images of MEFs treated with either DMSO (control) 
or 50 µM C12 for 4 hours (typical of three independent experiments.  The 
mitochondrial marker Tom20 is shown in red, cytochrome c in green, and DAPI 
in blue.  Following treatment with C12, staining of cytochrome c became diffuse 
and lost its co-localization with Tom20.  Arrowheads indicate cells in which 
cytochrome c redistributed from mitochondria to the cytosol and nuclei.  (B) 
Cytochrome c is released from both WT and caspase-3/7-DKO MEFs to similar 
degrees upon C12 exposure.  Cytochrome c release from mitochondrial was 
quantified by calculating the punctate/diffuse index, defined as the standard 
deviation of the mean pixel intensity of cytochrome c staining for each cell.  
Data represent means ± standard deviations of three independent experiments 
with at least 100 cells in each experiment.  Asterisks indicate P < 0.05 (*), 
Student's unpaired t test.  (C) The intracellular distribution of Tom20 was 
evaluated by determining the punctate/diffuse index.  Summary data show the 
means ± standard deviations of the punctuate/diffuse index calculated for more 








2.3.4  C12 induces apoptosis independent of caspase-8 in MEFs.  
The “initiator” caspase-8 mediates extrinsic pathway initiated at the plasma 
membrane, whereas the “initiator” caspase-9 is responsible for the 
mitochondria-dependent intrinsic pathway (92).  Activation of extrinsic and 
intrinsic apoptosis pathways has been reported in cells treated with C12, but it 
is not clear to what degree each pathway contributes to cell death (65, 94, 97, 
107).  To systematically investigate which apoptotic pathway is involved, we 
first examined MEFs deficient in caspase-8 and their wild-type counterparts 
(Figure 2.4A).  Consistent with a previous report (108), MEFs lacking caspase-8 
were resistant to the combined treatment of recombinant human TNF-α protein 
and the Smac mimetic TL-32711 (Figure 2.4B).  Upon exposure with C12, 
similar levels of cell death (Figure 2.4C) and activated caspase-3/7 (Figure 
2.4D) were detected in both WT and caspase-8-KO MEFs.  Moreover, C12 
triggers activation of caspase-3 and caspase-7 regardless of caspase-8 
expression (Figure 2.4E).  While more caspase-3 was cleaved in WT MEFs 
exposed to C12, higher levels of caspase-7 activation were detected in C12-
treated caspase-8-KO MEFs.  Similar levels of PARP cleavage was observed in 
both WT and caspase-8-KO MEFs, which is in agreement with the cell death 











Figure 2.4.  Caspase-8 activation is not involved in C12-induced apoptosis. 
(A) Caspase-8 expression in MEFs was evaluated by western blot.  (B) WT and 
caspase-8-KO MEFs were cultured with the indicated combination of 
recombinant human TNF-α and the Smac mimetic TL-32711.  Cell viability was 
determined following 24 hour-exposure by measuring propidium iodide DNA 
dye exclusion.  (C) The cytotoxicity of C12 on WT and caspase-8-KO MEFs 
was assessed 24 hours after treatment.  (D) Caspase-3/7 activities were 
evaluated 24 hours after C12 treatment.  (E) Upon the treatment of C12 for 12 
hours, activation of caspase-3 and caspase-7 in WT and caspase-8-KO MEFs 
was evaluated by western blot.  The molecular weight markers were labeled on 
the left (kD).  All data are shown as means ± standard deviations of three 
independent experiments.  Asterisks indicate P < 0.01(*); Student's unpaired t 












2.3.5.  Caspase-8 is not involved in C12-evoked human tumor cell death.  
To further validate the role of caspase-8 in C12-indcued cell death, we stably 
reduced caspase-8 expression in human colorectal carcinoma HCT116 and 
human pancreatic carcinoma Panc-1 by shRNA (Figures 2.5A and 2.5D).  
As expect, HCT116 and Panc-1 cells with reduced caspase-8 expression 
exhibited resistance to the combined treatment of TNF-α and the protein 
synthesis inhibitor cycloheximide (Figures 2.5B and 2.5E).  In contrast, C12 
caused similar levels of cell death in both HCT116 and Panc-1 cells regardless 
of caspase-8 expression (Figures 2.5C and 2.5F).  These data provide more 








Figure 2.5.  Caspase-8 is not involved in C12-induced human tumor cell death. 
(A) Caspase-8 expression in HCTT116 cells was stably reduced by shRNA. 
The expression levels of caspase-8 were determined by western blot. (B) 
HCT116 cells were cultured with the indicated combination of recombinant 
human TNF-α protein and cycloheximide (CHX).  Cell viability was determined 
following 48 hour-exposure.  (C) The cytotoxicity of C12 on HCT116 cells was 
assessed 48 hours after C12 treatment.  (D) Stable reduction of caspase-8 
expression in Panc-1 cells was evaluated by western blot.  (E) TNF-α protein 
and cycloheximide (CHX) triggered more cell death in vector control Panc-1 
cells than caspase-8 shRNA cells following 24 hour exposure.  (F) C12 induced 
equivalent cell death in vector-control and caspase-8-deficient Panc-1 cells 
after 24 hour treatment.  Data are presented as means ± standard deviations of 
three independent experiments.  Asterisks indicate P < 0.05 (*), Student's 











2.3.6.  C12 induces MOMP independent of caspase-8. 
To further investigate the role of caspase-8 in C12-initiated apoptotic signaling, 
we studied the involvement of caspase-8 in depolarization of ∆mito induced by 
C12.  Consistent with its effects on cell viability and caspase-3/7 activation, 
deficiency in caspase-8 expression failed to affect the ability of C12 to induce 
rapid depolarization of Δmito (Figure 2.6).  These data indicate that the 






















Figure 2.6.  C12 induces mitochondrial membrane potential depolarization 
independent of caspase-8. 
(A) Mitochondrial membrane potentials of WT and caspase-8-KO MEFs loaded 
with JC-1 were determined by fluorescence microscopy upon treatment with 50 
M C12 and 10 M FCCP.  Typical results from three independent experiments 
are shown.  (B) C12 caused equivalent mitochondrial depolarization in WT and 
caspase-8-KO MEFs.  Data are presented as means ± standard deviations of 3 
independent experiments.  Asterisks indicate P < 0.05 (*), Student's unpaired t 















2.3.7.  C12 exclusively triggered mitochondria-dependent intrinsic apoptosis 
pathway. 
Next, we investigated whether the “initiator” caspase-9 was responsible for 
C12-induced apoptosis.  For this purpose, MEFs lacking caspase-9 expression 
and corresponding wild-type MEFs were examined (Figure 2.7A).  Two 
chemotherapeutic drugs etoposide and actinomycin D known to evoke 
mitochondria-dependent intrinsic apoptosis pathway only induced cell death in 
wild-type but not in caspase-9-KO MEFs (Figures 2.7B-C).  Unlike their wild-
type counterparts, MEFs deficient in caspase-9 were completely resistant to 
C12 treatment (Figure 2.7D).  Importantly, C12 failed to evoke any caspase-3/7 
activation in MEFs lacking caspase-9 expression (Figure 2.7E).  Furthermore, 
cleavage of caspase-3 and caspase-7 was only found in wild-type MEFs treated 
with C12, but not in caspase-9-KO-MEFs (Figure 2.7F).  Overall, these data 
suggested that C12 induces apoptotic signaling largely through activating the 














Figure 2.7.  C12-induced apoptosis is dependent on caspase-9. 
(A) Caspase-9 expression in MEFs was determined by western blot.  (B) Wild-
type and caspase-9-KO MEFs were treated for 48 hours with various 
concentrations of etoposide (etop), and cell viability was measured.  (C) Wild-
type and caspase-9-KO MEFs were cultured with or without 0.5 g/ml 
actinomycin D (actD) for 24 hours, and cell viability was evaluated.  (D) Cell 
viabilities of wild-type and caspase-9-KO MEFs were measured 48 hours after 
treatment with different doses of C12.  (E) Caspase-3/7 activities were 
determined for wild-type and caspase-9-KO MEFs treated with different doses 
of C12 for 24 hours.  (F) Activation of caspase-3 and caspase-7 was evaluated 
by western blot following 16 hour-exposure of C12.  The molecular weight 
markers were labeled on the left (kD).  All the data are shown as means ± 
standard deviations of three independent experiments.  Asterisks indicate P < 











2.3.8.  C12 induced MOMP independent of caspase-9. 
To further explore the roles of caspase-9 in MOMP mediated by C12, Δmito 
was measured in WT and caspase-9-KO MEFs.  In contrast to its effects on cell 
viability and caspase-3/7 activation (Figures 2.7), deficiency in caspase-9 
expression did not affect the ability of C12 to induce rapid depolarization of 
Δmito (Figure 2.8), indicating that caspase-9 was not involved in C12- induced 
MOMP.  To further validate this notion, we examined cytochrome c 
redistribution from mitochondria to the cytosol and nuclei upon C12 exposure 
using immunofluorescence staining.  While C12 evoked the release of 
cytochrome c from mitochondria to the cytosol and nuclei regardless of 
caspase-9 expression, Tom20 displayed typical punctate and perinuclear 
mitochondrial distribution following C12 treatment (Figure 2.9A).  Moreover, 
C12 caused similar level of cytochrome c release from mitochondria in WT and 
caspase-9-KO MEFs, whereas Tom20 was retained in mitochondria (Figures 
2.9B-C).  Taken together, these data indicated that C12 causes acute MOMP 
independent of any “initiator” caspase, suggesting that the effects of C12 on 



















Figure 2.8.  C12-induced mitochondrial potential decrease is independent of 
caspase-9.  
(A) WT and caspase-9-KO MEFs were loaded with JC-1, and fluorescence was 
measured using imaging microscopy during sequential treatment with 50 M 
C12 and 10 M FCCP.  Typical results from three similar experiments are 
shown.  (B) Summary of depolarization of Δmito in WT and caspase-9-KO 
MEFs.  The data are shown as means ± standard deviations of 3 independent 









Figure 2.9.  C12-induced caspase-9 activation occurs downstream of 
mitochondrial membrane permeabilization.  
(A) Representative confocal images of MEFs treated with either DMSO (control) 
or 50 µM C12 for 4 hours. Tom20 is shown in red, cytochrome c in green, and 
DAPI in blue.  Arrow heads indicate cells with cytochrome c diffusing in the 
cytosol and nuclei.  (B) Summary data showing cytochrome c release upon C12 
exposure.  Cytochrome c release from mitochondria was quantified by 
calculating the scaled punctate/diffuse index.  Data are presented as mean ± 
standard deviations of the punctuate/diffuse index calculated for 3 independent 
experiments with at least 100 cells in each experiment.  Asterisks indicate P < 
0.05 (*), by Student’s unpaired t test.  (C) The punctate/diffuse index of 
intracellular Tom20 was calculated.  The data are the means ± standard 
deviations of 3 independent experiments with at least 100 cells in each 











2.3.9.  C12 depolarizes mitochondria without influencing mitochondrial 
morphology. 
Changes in mitochondrial morphology during certain paradigms of apoptosis 
have been associated with depolarization of mitochondria and subsequent 
release of cytochrome c (109).  To investigate the possible involvement of 
mitochondria morphology in C12-induced mitochondrial depolarization, we 
carried out experiments to evaluate mitochondrial morphology and membrane 
potential using time-lapse confocal microscopy on single A549 cells.  To this 
purpose, fluorescent signals of GFP targeted to mitochondrial matrix and the 
mitochondrial potential indicator TMRE were recorded simultaneously to 
measure mitochondrial morphology and membrane potential respectively.  As 
shown in Figure 2.10, C12 depolarized mitochondrial potential within 10 
minutes of addition to the live cells.  Following an established protocol (110), we 
evaluated mitochondrial morphology by measuring mitochondrial 
interconnectivity and elongation.  C12 did not appear to alter mitochondrial 
morphology within the time window of the measurement, indicating that C12-
triggered mitochondrial potential depolarization occurs without changes in 









Figure 2.10.  C12 depolarizes mitochondrial membrane potential without 
affecting mitochondrial morphology. 
(A) Time-lapse confocal microscopy on single A549 cells was carried out in the 
presence of the vehicle control DMSO or 100 M C12.  Fluorescent signals of 
mitochondrial matrix-targeted GFP and TMRE were recorded simultaneously to 
evaluate mitochondrial morphology and membrane potential respectively. 
Typical traces of mitochondrial area/perimeter ratio, inverse circularity, and 
membrane potential of a single cell were shown.  (B) Summary data (mean ± 
SEM) pooled from three independent coverslips run on two separate days 
depicting morphology and membrane potential at time 0 and after 10 minutes 
exposure to vehicle control or C12.  Asterisk indicates P < 0.05 (*) by student’s 













2.3.10.  Lysosomes are not involved in cell death induced by C12. 
There is evidence of cross-talk between mitochondria-mediated apoptosis and 
lysosomal cell death (111).  Given the rapid depolarization of Δmito induced by 
C12, it is possible that lysosomes are involved in C12-triggerred caspase-
independent MOMP.  The oxidative stress inducer hydrogen peroxide (H2O2) 
has been shown to cause lysosomal membrane permeabilization (LMP) and 
subsequent apoptosis, which is blocked by a highly potent iron chelator 
desferrioxamine (DFO) (112, 113).  Following pre-incubation with DFO, wild-
type and caspase-9-KO MEF cells were treated with H2O2 and C12 
respectively.  As expected, both H2O2 and C12 failed to induce cell death in 
capsapse-9-KO cells.  Consistent with previous studies, the cell death induced 
by H2O2 was markedly reduced by DFO pre-treatment (Figure 2.11A).  In 
contrast, DFO did not have any significant influence on cell death evoked by 
C12 (Figure 2.11B), providing evidence that lysosomal cell death is unlikely 





Figure 2.11. Lysosomal membrane permeabilization is not involved in cell death 
induced by C12. 
Wild-type and caspase-9-KO MEFs were cultured with or without 1 mM DFO for 
2 hours. Following DFO removal, 0.7 mM H2O2 or 100 M C12 was added to 
cells respectively.  Cell death was measured 24 hours after H2O2 treatment (A) 
or 48 hours after C12 treatment (B).  Data are shown as means ± standard 
deviations of three independent experiments.  Asterisks indicate P < 0.05 (*), 








2.3.11.  C12 directly induces MOMP in vitro. 
Since C12 depolarized Δmito starting within 1 minute and achieving complete 
effect within 10-15 minutes independent of both “initiator” caspases and 
“effector” caspases (Figures 2.2, 2.6 and 2.8), we reasoned that C12 could 
possess activities that directly permeabilize mitochondria.  To this purpose, we 
examined the effects of C12 on mitochondrial outer membrane integrity in vitro.  
Mitochondria isolated from WT MEFs were exposed to DMSO (control) or to 30 
or 300 µM C12.  We assessed the amount of cytochrome c released from the 
mitochondria using western blot analysis (Figure 2.12A).  In a manner 
dependent on [C12], less cytochrome c was detected in mitochondrial fractions, 
with concomitant increase of cytochrome c in released fractions (Figure 2.12B). 
These data indicated that C12 is able to permeabilize mitochondria directly in 
vitro. Overall, our data suggest that C12 evokes a mitochondrial apoptotic 
signaling pathway in which C12 directly permeabilizes mitochondria, leading to 

















Figure 2.12.  C12 directly induces MOMP in vitro.   
(A) Mitochondria were isolated from wild-type MEFs and incubated with C12 for 
1 hour.  Release of cytochrome c from mitochondria was determined by 
western blot. (B) The intensities of cytochrome c in mitochondrial (P) and 
cytosolic (S) fractions shown in (A) were quantified using ImageJ (NIH). 
Cytochrome c release is represented as a percentage of the sum of the protein 
intensity in mitochondrial and released fractions.  Mean ± standard deviation for 
four independent experiments are shown.  Asterisks indicate P ˂ 0.01 (**) by 
Student’s unpaired t test. (C) C12 permeabilizes mitochondria, subsequently 















2.4.  DISCUSSION 
The quorum-sensing molecule C12 evokes apoptosis in a variety of mammalian 
cells (65, 66, 69, 87, 88).  Several signaling pathways leading to apoptosis have 
been associated with C12 cytotoxicity.  In addition to activating the intrinsic 
apoptosis pathway, C12 also activates caspase-8, implicating a role of the 
extrinsic apoptosis cascade in C12-induced apoptosis (65, 93, 94, 97).  One 
possible scenario is that C12 functions as a ligand that is recognized by 
receptors on the plasma membrane.  However, the interplay between the 
intrinsic and extrinsic pathways and the functions of key molecules involved had 
not been clearly elucidated previously.  In this study, we present evidence that 
caspase-3/7 and caspase-9 but not caspase-8 are essential for C12-induced 
apoptotic cell death, indicating that C12 selectively triggers the mitochondria-
dependent intrinsic apoptotic pathway.  Therefore, the events associated with 
activating a plasma membrane receptor are likely secondary responses to 
MOMP.   
 
In mitochondria-mediated intrinsic apoptosis signaling cascade, it is generally 
believed that MOMP and cytochrome c release occur upstream of caspase-9 
activation, which subsequently leads to activation of caspases-3/7(34).  
However, the involvement of caspases-3/7 activation in MOMP has only been 
carefully examined for limited number of apoptotic stimuli.  In the study where 
caspase-3/7-DKO MEFs was first reported, UV irradiation is found to trigger 
intrinsic apoptosis pathway through activating caspase-3/7 (104).  Unlike their 
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wild-type counterparts, cells deficient in caspase-3/7 expression maintain their 
Δmito upon UV irradiation.  This result provides evidence that caspase-3/7 
could regulate the initial phase of intrinsic apoptosis signaling in certain 
apoptotic paradigms, raising the possibility of existing a feedforward loop 
among MOMP, caspase-9 activation and caspase3/7 activation.  In contrast, 
our studies provide unequivocal evidence that C12 evokes MOMP independent 
of both “initiator” and “effector” caspases.  The dispensable roles of caspases in 
C12-induced MOMP suggest that C12 may exert its pro-apoptotic effect without 
the involvement of signaling upstream of mitochondria. 
 
Several signaling pathways linked to apoptosis initiation, including JAK/STAT 
(66), MAPK and eIF2 pathways (91) have been implicated in C12-evoked cell 
death.  Most of these apoptosis-associated signaling pathways are normally 
involved in multiple steps of signal transduction, and the biological events 
reflective of these signaling cascades are largely observed hours following C12 
incubation.  In contrast, depolarization of ∆mito, the earliest step of MOMP (5, 
101), is always detected within minutes following C12 exposure and reaches its 
maximal levels in 20 minutes (Figures 2.2, 2.6 and 2.8; also see (65, 95, 107, 
114).  Thus, it appears that activation of JAK/STAT, eIF2a and MAPK signaling 
pathways may be secondary to MOMP initiation in the C12-triggered apoptosis 
cascade.   
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C12 has also been demonstrated to trigger the ER stress pathway (65, 90, 114, 
115).  Release of ER Ca2+ into the cytosol is observed within minutes of C12 
exposure, which is implicated in C12-induced apoptosis (65, 114, 115).  Since 
the effects of ER stress on ∆mito occurs several hours following ER Ca2+ pool 
depletion (102), the likelihood that C12-induced ER Ca2+ release directly causes 
depolarization of ∆mito is low.  Furthermore, recent research indicates that ER 
stress-mediated apoptosis requires the pro-apoptotic Bcl-2 proteins Bak and 
Bax to permeabilize mitochondria (102, 116, 117), which is inconsistent with the 
evidence that C12 triggers depolarization of ∆mito independent of Bak and Bax 
in various cellular systems (93, 95).  Thus, it is unlikely that ER stress signaling 
is directly involved in C12-mediated depolarization of ∆mito.  Conceivably, C12 
or its metabolite(s) acts directly on mitochondria and permeabilizes them.  In 
support of this notion, our in vitro studies demonstrate that C12 directly 
permeabilize mitochondria (Figure 2.12). 
 
As a lactone, C12 is known to be hydrolyzed into a carboxylic acid by 
paraoxonase 2 (PON2), an enzyme with lactonase and arylesterase activities in 
vitro (76).  Intracellular PON2 has been demonstrated to hydrolyze C12 and 
cause subsequent intracellular acidification, which is thought to mediate 
biological responses to C12, such as triggering stress signaling (115). However, 
the association between C12-evoked intracellular acidification and 
depolarization of ∆mito remains unclear.  Our previous studies demonstrated 
that PON2 promotes C12-induced apoptosis in various cellular systems (95, 
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114).  In addition to its localization on the ER membrane and plasma membrane 
(118), PON2 has been shown also to be localized in mitochondria (73).  One 
possibility is that PON2 cleaves C12 into a pro-apoptotic metabolite(s) that 
permeabilizes mitochondria (91). C12 or a PON2-mediated derivative might 
also react with other molecules (e.g. phosphorylation) in cells to generate 
secondary metabolite(s) with stronger pro-apoptotic activities.  Alternatively, 
PON2 has anti-oxidant properties that modulate peroxidation of membrane 
lipids (118) and may regulate intracellular lipid biogenesis (119, 120), which 
might affect mitochondrial outer membrane lipid composition in such a way that 
C12 preferentially inserts into mitochondria. 
 
Whatever the molecular details of C12 action on mitochondria, our study has 
shown that C12 induces a unique apoptotic signaling pathway in which C12 or 
C12 metabolite(s) acts as a mitolytic molecule that acts to directly permeabilize 
mitochondria, releasing cytochrome c to activate caspases 9, 3 and 7 and 
subsequent downstream signaling leading to apoptosis and cell death
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CHAPTER III 
N-(3-OXO-ACYL) HOMOSERINE LACTONE INHIBITS TUMOR GROWTH 
INDEPENDENT OF BCL-2 PROTEINS 
 
3.1.  INTRODUCTION 
Quorum sensing is a bacterial intercellular communication system that 
constitutively produces, releases, and detects small diffusible autoinducers that 
are similar to mammalian hormones (58). The gram-negative human pathogen 
Pseudomonas aeruginosa uses N-(3-oxododecanoyl)-L-homoserine lactone 
(C12) as a quorum-sensing signal (82, 83). 
 
Recent studies have shown that C12 is not only important in regulating bacterial 
virulence genes but also interacts with eukaryotic cells and modulates cell 
physiology, such as triggering cell death (60). C12 has been demonstrated to 
cause apoptosis in a variety of cancer cells (66, 69-71). C12 induces apoptosis 
through inhibiting the phosphatidylinositide 3-kinases and Akt/PKB pathway and 
diminishing STAT3 activities in breast carcinoma cells (66). In pancreatic 
carcinoma cells, C12 also triggers apoptotic signaling and inhibits cell migration 
(70). C12 decreases the expression of thymidylate synthase and enhances the 
activity of chemotherapeutic agents, 5-fluorouracil (5- FU), Tomudex and Taxol in 
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colorectal and prostate cancer cells. Recently, a derivative of C12, 3-oxo-12-
phenyldodecanoyl-L-homoserine lactone, has been identified as another cancer 
cell growth inhibitor (69). Comparative SAR analysis demonstrates that long acyl 
side chains with a 3-oxo substitution are essential for C12’s anti-cancer effect 
(69). In light of its function of triggering tumor cell death, C12 displays promise as 
a cancer treatment. However, detailed apoptotic signaling of C12 remain unclear. 
Additionally, whether or not C12 cytotoxicity in vitro is relevant; to tumor growth in 
vivo, has never been studied.  
 
Resistance toward apoptosis is a hallmark of most, perhaps all, types of human 
cancer (121, 122). Bcl-2 proteins are the major regulators of apoptotic signaling 
pathways and can be classified into anti-apoptotic and pro-apoptotic groups.  
Anti-apoptotic Bcl-2 proteins; such as Bcl-2, are considered to protect against 
mitochondrial outer membrane permeabilization (MOMP) during apoptosis, 
whereas pro-apoptotic Bcl-2 members such as Bax and Bak promote MOMP (42, 
123). The expression of individual Bcl-2 proteins in different types of cancer has 
been used as an independent prognostic marker (122). Studies in various human 
tumors showed that loss of Bax expression, or increased expression of Bcl-2, are 
associated with their resistance to chemotherapy (124-127). Accordingly, one 
strategy for cancer therapy is to identify agonists that activate apoptotic pathway 
independent of Bcl-2 proteins in tumor cells (128-130). 
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To gain insights into the mechanism of C12-evoked tumor cell apoptosis, we 
evaluated the cytotoxic effects of C12 on tumor cells in vitro, the inhibitory effects 
of C12 on tumor growth in vivo and the role of pro- and anti-apoptotic Bcl-2 
proteins in C12-induced apoptosis were systematically examined. C12 inhibited 
the tumor growth through inducing apoptosis in a Bcl-2 protein-independent 
manner. Our study reveals a unique anti-tumor function of C12, which may lead 


















3.2.  MATERIALS AND METHODS 
3.2.1.  Reagents 
N-(3-oxododecanoyl)-homoserine lactone (C12), polybrene and actinomycin D 
were purchased from Sigma (St. Louis, MO). Propidium iodide (PI), CM-
H2DCFDA (5-(and-6)-chloromethyl-2', 7’-dichlorodihydrofluorescein diacetate, 
acetyl ester), TMRE (tetramethylrhodamine, ethyl ester) and TOTO-3 were 
obtained from Invitrogen (Carlsbad, CA). Unless otherwise stated, all reagents 
were dissolved in dimethyl sulfoxide (DMSO). Dulbecco’s Modified Eagle’s 
Medium (DMEM), penicillin/streptomycin, trypsin, and L-glutamine were obtained 
from Mediatech (Manassas, VA), and fetal bovine serum was purchased from 
Gemini (Broderick, CA). Caspase-Glo assay 3/7 kit was purchased from 
Promega (Madison, WI). Antibodies (Abs) for western blot were anti-β-actin mAb 
(Sigma), anti-Bcl-2 mAb; anti-Bax pAb (Santa Cruz; Dallas, TX), anti-Bak pAb 
(Millipore; Billerica, MA), anti-Mcl-1 pAb (Abcam; Cambridge, MA), anti-Noxa pAb 
(Novus; Littleton, CO), anti-Puma pAb (ProSic; Poway, CA) peroxidase-
conjugated goat anti-rabbit IgG (Thermo Fisher; Waltham, MA) and peroxidase-
conjugated goat anti-mouse IgG (Thermo Fisher). 
 
3.2.2.  Plasmids  
pBABE-hBcl-2-IRES-EGFP was generated by cloning human Bcl-2 cDNA into 
pBABE-IRES-EGFP. pMIG-hMcl-1-IRES-EGFP and pMIG-hBcl-xL-IRES-EGFP 
was a gift from Dr. Levi Beverly (University of Louisville). The plasmid identities 
were validated by sequencing. Lentiviral human PON2 shRNA plasmid was 
purchased from Santa Cruz. 
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3.2.3  Retrovirus production and cell culture 
Retrovirus were generated as described previously (99). HCT116 cells 
expressing different levels of Bak and Bax were obtained from Dr. Richard Youle 
(National Institutes of Health). HCT116 cells stably expressing Noxa shRNA or 
the control luciferase shRNA were described previously (131). Puma-deficient 
HCT116 cells were acquired from Dr. Bert Vogelstein (John Hopkins University). 
NSCLC cell line A549 cells were obtained from ATCC, which were produced 
from adenocarcinomic alveolar basal epithelial cells of a lung cancer patient 
(132). NCI-H1299 cells were also acquired from ATCC. A549 cells expressing 
Mcl-1shRNA or control scramble shRNA were described previously  (133). A549 
cells overexpressing Bcl-2, Bcl-xL or Mcl-1 were produced by retroviral infection 
as described previously (99). NHBE cells were purchased from Lonza 
(Walkersville, MD). hT/LT/Ras HBE cells were obtained from Professor Barrett 
Rollins (Harvard Medical School). Lewis Lung Carcinoma cells, NCI-H1299 and 
A549 cells were cultured as described previously (134). NHBE and hT/LT/Ras 
cells were grown in BEGM supplemented with SingleQuots (LONZA). HCT116 
cells were grown as described previously (135). Cells were all cultured in a 5% 
CO2 humidified incubator at 37oC.  
 
3.2.4  Cell death analysis and Chou-Talalay synergism assay 
Cell viability was determined by propidium iodide exclusion using flow cytometry 
as described previously (134). The synergistic effect of C12 and ABT-737 on cell 
viability was evaluated by Chou-Talalay median dose effect assay. IC50 of C12 
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and ABT-737 on NCI-H1299 or A549 was first determined. Various combinations 
of C12 and ABT-737 at a constant ratio above or below their IC50 values were 
added to cells. Following incubation for the indicated time, cell viability was 
evaluated and Fa (fractional activity) was determined as the ratio between the 
cell death levels of drug-treated cells and those of untreated control cells. 
Combination index (CI) was calculated by the CompuSyn software (Biosoft, 
Cambridge, UK). 
 
3.2.5.  Caspase-3/7 activity and TUNEL labeling  
Caspase-3/7 activities were measured using a Caspase-Glo assay kit (Promega, 
Madison, WI) as described previously (136). The proluminescent substrate 
containing the amino acid sequence Asp-Glu-Val-Asp (DEVD) is cleaved by 
activated caspase-3/7, leading to the release of a luciferase substrate 
(aminoluciferin) and the generation of luminescent signal. Data were presented 
as relative luminescent units (RLU) which were normalized to the corresponding 
values of control cells as an indicator of caspase 3/7 activities. TUNEL labeling 
was carried out by the Pathology Research Services Laboratory at University of 
Washington. The slides were scanned by a ScanScope CS digital slide scanner 






3.2.6.  Measuring Δmito using imaging microscopy  
Cells were incubated with 10 μM Δmito probe JC1 in growth media for 10 
minutes at room temperature followed by three washes with Ringer’s solution. 
Dye-loaded cells were mounted onto a chamber on the stage of a Nikon Diaphot 
inverted microscope with a Fluor 20x objective (0.75 NA) at room temperature. 
Treatments were made by diluting stock solutions into Ringer’s solution at the 
indicated concentrations. Fluorescence imaging measurements of Δψmito were 
performed as reported previously (93, 138). Briefly, a charge coupled device 
camera collected JC-1 emission images using filter wheels (Lambda-10, Sutter 
Instruments, Novato, CA). Images were corrected for background (region without 
cells). Quantitative data are reported as JC1 fluorescence ratios normalized to 
minimal JC1 ratios obtained at the start of the experiment and maximal JC1 
ratios obtained after 5 μM FCCP treatment:  Normalized JC1 Ratio = (Ratio at a 
given time - minimal Ratio) / (maximal ratio - minimal Ratio) * 100%. Normalized 
JC1 ratios at plateau (before addition of FCCP) from different experiments have 
been averaged for summary charts. 
 
3.2.7.  Immunofluorescence Microscopy 
For immunofluorescence staining of A549 and HCT116 cells, cells plated 24 
hours earlier were incubated for 3 hours with either vehicle (DMSO) or 50 µM 
C12 in Ringer’s solution. The immunofluorescence staining of cytochrome c was 
carried out as described previously (134).  Images were captured using a Nikon 
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Eclipse Ti confocal microscope with a 40x CFI Plan Fluor objective (NA 0.6). To 
minimize variability, the same microscope settings were used for all experiments.  
For immunofluorescence staining of tumor sections, tumor sections (5 μm) were 
treated with antigen retrieval procedure by boiling in 10% Triton x-100, then 
slowly cooled down at room temperature. After incubating with the blocking buffer 
(1× PBS, 0.2% Triton X-100, 5% goat serum), the slides were incubated with 
antibodies against activated caspase-3 (Cell signaling) overnight at 4oC. 
Following three 10-minute washes, slides were incubated with goat anti-rabbit 
IgG (Alexafluor-568, Invitrogen) for 1 hour. The fluorescence was visualized by 
confocal microscopy using a 40x CFI Plan Fluor objective (NA 0.6) and was 
analyzed using ImageJ software (NIH) as described previously (139). 
 
3.2.8.  In vivo animal studies  
For C12 toxicity studies, DMSO or C12 (25 mg/kg/day) was administered 
intraperitoneally each day in 8 week-old C57BL/6 mice or in 6 week-old athymic 
nude mice. All organs were collected and weighted at sacrifice. 
 
For transplanted tumors in C57BL/6 mice, eight-week old C57BL/6 female mice 
(Jackson Laboratories; Bar Harbor, ME) were inoculated subcutaneously (s.c.) 
with 1×106 Lewis Lung Carcinoma cells on the right flank. Tumors were 
measured daily with dull edged Vernier calipers (V = L×W2/2). After tumor size 
reached around 100 mm3, animals with size-matched tumors were divided into 
control group and C12 group. DMSO or C12 was administered intraperitoneally 
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each day. At the end of the experiments, tumors were excised for apoptosis 
evaluation. For the study of transplanted human tumors, female athymic nude 
mice (5-7 weeks) were purchased from Harlan Laboratories (Indianapolis, IN). 
Wild-type HCT116 cells and Bax/Bak DKO HCT116 cells (3.0×107/ml), wild-type 
A549 cells and Bcl-2-overexpressing A549 cells (3.0×107/ml) were resuspended 
and mixed 1:1 (vol/vol) with Matrigel (BD Biosciences), then 0.1 ml mixture of 
cells and Matrigel was injected s.c. on the right flank of mice. All animals with 
size-matched tumors were divided into two groups (control and C12) when the 
tumor size reached around 100 mm3. For HCT116 and Bax/Bak DKO HCT116 
tumors, DMSO or C12 was administered intraperitoneally each day. DMSO or 
etoposide (40 mg/kg/day) was administered intraperitoneally once every other 
day. For wild-type A549 tumors, animals were treated with C12 for 6 
times/week. For Bcl-2 over-expressing A549 cells tumors, DMSO or C12 was 
administered with C12 each day. At the end of the experiments, tumors were 
excised for apoptosis evaluation. 
 
3.2.9.  Statistical analysis 
Results are presented as mean ± standard deviation of at least three 
independent experiments. Statistical analysis was performed using Student’s 
two-tail t-test. A p value < 0.05 was considered significant.  
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3.3.  RESULTS  
3.3.1.  C12 inhibits lung tumor growth and induces tumor cell apoptosis in vivo. 
The cytotoxic effects of C12 on tumor cells have been reported previously (66, 
69-71, 140), but whether they are selective for transformed cells was unknown. 
To investigate whether oncogenic transformation influences the cytotoxicity of 
C12, we studied normal human bronchia/tracheal epithelial (NHBE) and 
corresponding HBE immortalized and transformed successively by telomerase, 
SV40 large T antigen and activated Ras (H-ras V12) (141-144). This is a well-
established epithelial cell malignant transformation system related to human lung 
cancer. Following C12 treatment, transformed HBE exhibited higher levels of cell 
death (Figure 3.1A) and caspase-3/7 activation (Figure 3.1B) compared with their 
untransformed counterparts, indicating that C12 induces apoptosis preferentially 
in transformed cells.  
 
To investigate the relevance of C12 cytotoxicity on transformed cells to tumor 
growth in animals, we examined the effects of C12 on the growth of established 
Lewis Lung Carcinoma (LLC) tumors. As shown in Figure 1C, transplanted 
tumors grew much more slowly in C12-treated mice than in vehicle-treated mice, 
revealing a dose-dependent anti-tumor activity of C12 as a single agent.  
To test the involvement of apoptosis in tumor growth inhibition, established LLC 
tumors from mice were analyzed for caspase-3 activation through 
immunofluorescence staining (Figures 3.1D-E), western blot (Figures 3.1F-G) 
and TUNEL staining (Figures 3.1H-I). The percentage of TUNEL-positive cells 
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and the levels of activated caspase-3 were higher in tumors from C12-treated 
mice than in those of the control group, suggesting that apoptosis is involved in 









Figure 3.1.  C12 inhibits LLC tumor growth and induces tumor cell apoptosis in 
vivo in a dose-dependent fashion. 
(A-B) Cytotoxicity of C12 is affected by oncogenic transformation. C12’s effects on 
HBE cell viability (A) and caspase-3/7 activation (B) were examined. All data 
shown are mean ± standard deviation of 3 independent experiments. Asterisk 
indicates P < 0.05 (*) or P< 0.01 (**) by student's unpaired t test. (C) The inhibitory 
effects of C12 on the growth of LLC tumors were studied. Tumors were measured 
daily and tumor tissues were removed at the end of treatments. Data are shown as 
mean ± standard deviation of tumor volumes of 7 animals in either vehicle control 
or C12-treated group. Asterisk indicates P < 0.05 (*) by student’s unpaired t test. 
(D) Apoptotic cells in tumor sections were detected by immunofluorescence 
staining of activated caspase-3. Representative images of tumor sections are 
shown. Scale bar, 50 µm. (E) The percentage of activated caspase-3 shown in (D) 
was quantified using ImageJ software (NIH). Data are mean ± standard deviation 
of three independent tumor sections. Asterisk indicates P< 0.01 (**) by student's 
unpaired t test. (F) Expression of activated caspase-3 in tumor tissues was 
analyzed by western blot. (G) The relative expression levels of activated caspase-
3 shown in (F) were quantified by measuring intensities of western blot signals 
using ImageJ software and presented as arbitrary units. Data are mean ± standard 
deviation of three independent tumor samples. Asterisk indicates P < 0.05 (*) by 
student’s unpaired t test.  (H) TUNEL staining of apoptotic cells in control or C12-
treated tumor sections. Representative images are shown. Scale bar, 60 µm. (I) 
The percentage of apoptotic cells shown in (H) was quantified using ImageJ 
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software. Data are mean ± standard deviation of three independent tumor 























3.3.2.  C12 does not cause significant toxicity in mice. 
To examine whether C12 possesses non-specific toxicity to animals, we 
investigated the effects of administrating C12 to mice for extended periods of time.  
No significant changes in body weight and organ weight (spleen, kidney, liver, 
heart, lung) were observed for C12-treated C57BL/6 mice, showing no evidence of 
significant toxicity of C12 upon administration (Figures 3.2A and 3.2C). Similarly, 
C12 caused no significant change in body weight and organ weight (spleen, 













Figure 3.2.  Administrating C12 to mice does not affect body weight and organ 
weight. 
(A-B) DMSO or C12 (25 mg/kg/day) was administered intraperitoneally to C57BL/6 
mice (A) or athymic nude mice (B) daily. Body weights of mice were measured. 
Data are mean ± standard deviation of body weights of 5 animals in each group. 
(C-D) Effects of C12 on organ weights in C57BL/6 mice (C) and athymic nude 
mice (D) were evaluated. Spleen, kidney, liver, heart and lung of the indicated 
mice were weighed at sacrifice. Each organ weight was normalized as the 
percentage of corresponding body weight. Data are mean ± standard deviation of 














3.3.3.  C12 and conventional therapeutic drugs induce tumor cell death 
synergistically. 
In order to explore the therapeutic potential of C12, we studied the combinatorial 
effects of C12 and therapeutic drugs. A549 and NCI-H1299 cells were treated with 
various concentrations of C12 and ABT-737, an inhibitor of Bcl-2 and Bcl-xL, at a 
constant dose ratio. Cell death was measured at the indicated times, and the 
combination index (CI) values were determined (Figure 3.3).  As shown in figure 
3C and 3F, in the range of tested drug concentrations, CI values were smaller than 
1, indicating that C12 and ABT-737 exhibited synergistic cytotoxic effects on A549 









Figure 3.3.  C12 functions synergistically with ABT-737 to induce tumor cell death.   
(A) C12 sensitized A549 cells to ABT-737 treatment. Upon treatment with different 
combinations of C12 and ABT-737 for 48 hours, the percentage of cell death of 
A549 cells was measured. The data depict mean ± standard deviation of three 
independent experiments. (B) A549 cells were treated with the indicated 
combination of C12 (10-100 µM) and ABT-737 (3.3-33.3 µM) for 48 hours, and cell 
death was measured. The data represent mean ± standard deviation of triplicate 
experiments.  The experiments were performed independently three times. (C) 
The data shown in (B) was analyzed as described in MATERIALS AND 
METHODS. The values of combination index (CI) and fractional activity (Fa) were 
calculated. (D) NCI-H1299 cells were treated with different combinations of C12 
and ABT-737 for 48 hours, and cell viability was measured. The data are mean ± 
standard deviation of three independent experiments. (E) NCI-H1299 cells were 
cultured with the fixed combination of C12 (5-250 µM) and ABT-737 (4-200 µM) for 
48 hours, and cell death was determined. The data are mean ± standard deviation 
of triplicate experiments.  The experiments were performed independently three 
times. (F) The data shown in (E) was evaluated as described in MATERIALS AND 







3.3.4.  Anti-apoptotic Bcl-2 proteins do not affect C12 cytotoxicity. 
Anti-apoptotic Bcl-2 proteins are frequently overexpressed in human cancers and 
associated with chemotherapeutic resistance and relapse (145). To investigate 
the involvement of anti-apoptotic Bcl-2 proteins in C12-induced human tumor cell 
apoptosis, Bcl-2, Mcl-1 and Bcl-xL were stably overexpressed in A549 cells 
respectively by retroviral infection (Figures 3.4A, 3.5A and 3.5D). The anti-tumor 
drug actinomycin D caused less cell death and caspase-3/7 activation in Bcl-2-, 
Mcl-1- or Bcl-xL-overexpressing cells than in cells expressing the empty vector 
(Figures 3.4B-C, 3.5B-C and 3.5E-F). In contrast, C12 induced similar levels of 
cell death and caspase-3/7 activation in cells overexpressing Bcl-2, Mcl-1 or Bcl-
xL and the vector control cells (Figures 3.4B-C, 3.5B-C and 3.5E-F). To further 
explore the involvement of Mcl-1 in mediating C12-induced cytotoxicity, we 
examined A549 cells in which Mcl-1 expression was stably reduced by shRNA 
(146).  Actinomycin D but not C12 caused more cell death and caspase-3/7 
activation in Mcl-1-knockdown cells than the cells expressing the control 
scramble shRNA (Figures 3.5G-H), further validating that Mcl-1 expression is not 
vital for C12-induced apoptotic signaling.  
 
MOMP has been recognized to be a “no-return” step during mitochondria-based 
apoptotic signaling (105). To further investigate C12-initiated apoptosis in tumor 
cells, we studied the involvement of Bcl-2 in two key events of MOMP: 
depolarization of mitochondrial membrane potential (∆mito) and cytochrome c 
release. Depolarization of ∆mito was evaluated by determining the changes in 
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fluorescence of the voltage-dependent dye JC1 released from mitochondria into 
the cytosol and nucleus.  Within minutes of C12 exposure, mitochondria in A549-
vector cells and A549-Bcl-2 overexpressing cells were depolarized to the same 
degree (Figures 3.4D-E). Moreover, C12 caused cytochrome c release from 
mitochondria in both A549-vector and Bcl-2 or Mcl-1 over-expressing A549 cells 
(Figures 3.6 and 3.7). Taken together, these results indicate that overexpression 
of anti-apoptotic Bcl-2 proteins reduces apoptosis in response to the classical 














Figure 3.4.  C12 induces tumor cell apoptosis independent of anti-apoptotic protein 
Bcl-2. 
(A) Retrovirally overexpressed Bcl-2 in A549 cells was examined by western blot. 
(B) Cell viability was measured 48 hours after C12 or actinomycin D (ActD) 
exposure. (C) Caspase-3/7 activities were determined following 2 hour exposure 
to C12 and 24 hour exposure to actinomycin D. (D) C12’s effect on mitochondrial 
membrane potential is independent of Bcl-2.  A549-vector and A549-Bcl-2-
overexpressing cells were loaded with JC1, and its fluorescence was measured 
using imaging microscopy during the treatment with 100 M C12 and 5 M FCCP. 
Typical results from three independent experiments are shown. (E) C12 caused 
equivalent depolarization of mitochondrial potential in vector and Bcl-2-
overexpressing A549 cells.  All data are shown as mean ± standard deviation of 
three independent experiments. Asterisks indicate P < 0.05 (*); ns, no significant 






Figure 3.5.  Anti-apoptotic Bcl-2 protein Mcl-1 and Bcl-xL do not affect C12 
cytotoxicity.  
(A)The expression levels of Mcl-1 in the indicated A549 cells were determined by 
western blot. (B) Cell viability of the indicated A549 cells with or without Mcl-1 
over-expression was measured 48 hours after the treatment. (C) Caspase-3/7 
activities were determined after exposure to C12 for 2 hours and exposure to 
actinomycin D for 24 hours. (D) Bcl-xL was stably overexpressed in A549 cells by 
retroviral infection. (E) Cell death was measured after 48 hour-incubation of C12 or 
actinomycin D (1 µg/ml) in A549 cells without or with over-expressed Bcl-xL. (F) 
Caspase-3/7 activities were examined 32 hours after C12 or actinomycin D 
exposure. (G) After treating A549 cells expressing Mcl-1 shRNA or control shRNA 
with C12 or actinomycin D for 72 hours, cell death was measured. (H) Caspase-
3/7 activities were measured after 32 hour-incubation of C12 or actinomycin D in 
the indicated A549 cells. All data are presented as mean ± standard deviation of 
three different experiments that were carried out in triplicate. Asterisk indicates P < 







Figure 3.6. C12-induced cytochrome c release in tumor cells is independent of 
Bcl-2.  
Upon C12 exposure, cytochrome c is released from mitochondria in both A549-
vector and A549-Bcl-2 over-expressing cells.  Representative confocal images of 
A549 cells treated with either DMSO (control) or 100 µM C12 for 3 hours. 
Cytochrome c is shown in red, and DAPI is shown in blue. Following C12 













Figure 3.7. C12-induced cytochrome c release in tumor cells is independent of 
Mcl-1. 
After treating with 100 µM C12 of 3 hours, cytochrome c was released from 
mitochondria in both A549-vector and A549-Mcl-1 over-expressing cells. 




















3.3.5.  C12 blocks tumor growth independent of Bcl-2 protein. 
To determine whether anti-apoptotic Bcl-2 protein-independent C12 cytotoxicity 
is relevant in vivo, we examined its effects on the growth of tumors originated 
from A549 cells with different levels of Bcl-2 expression in athymic nude mice. As 
shown in Figures 3.8A-B, A549-Bcl-2 overexpressing tumors grew much faster 
than their vector control counterparts, which is consistent with the oncogenic 
function of Bcl-2 (147). C12 inhibited the growth of vector control A549 tumors 
and Bcl-2-overexpressing A549 tumors to a comparable degree. Inhibitory effects 
of C12 on tumor growth are likely attributed to apoptosis, as more TUNEL-
positive cells were detected in C12-treated tumors than vehicle-treated ones 
regardless of Bcl-2 expression levels (Figures 3.8C-D). Overall, these results 












Figure 3.8.  C12 inhibits tumor growth independent of Bcl-2. 
(A-B) Growth of A549-vector (A) and A549-Bcl-2-overexpressing tumors (B) in 
athymic nude mice treated with vehicle control or C12 (15 mg/kg/day). Data are 
shown as mean ± standard deviation of tumor volumes of 8 animals in either 
vehicle control (DMSO) or C12-treated groups. (C) Apoptotic cells in tumor 
sections were identified by TUNEL assay. Representative images of tumor 
sections from DMSO- and C12-treated mice are shown. Scale bar, 60 µm. (D) 
Summary of the data shown in (C). More apoptotic cells were detected in tumors 
of C12-treated mice than those of vehicle control mice. Mean ± standard deviation 
of three independent tumor sections. For all the data, asterisk indicates P < 0.05 














3.3.6.  Bak and Bax are not involved in C12-induced apoptosis. 
Previous studies show that C12 induces apoptosis in MEFs independent of Bak 
and Bax (98, 114) , two pro-apoptotic Bcl-2 members required for MOMP in 
almost all apoptotic paradigms (148). To clarify their role in C12-induced tumor 
cell apoptosis, human colon carcinoma HCT116 cell lines lacking Bak alone, Bax 
alone, or both Bak and Bax (Bak/Bax-DKO) were studied (Figure 3.9A). C12 
caused roughly equivalent cell death and caspase-3/7 activation in all the 
HCT116 cell lines examined, indicating that deficiency of Bak and Bax in 
HCT116 cells did not influence their responses to C12 (Figures 3.9B-C). Unlike 
C12, the therapeutic drug etoposide induced significant cell death and caspase-
3/7 activation in WT, Bax-KO and Bak-KO but not in Bak/Bax-DKO HCT116 cells 
(Figure 3.10A-B). Moreover, deficiency in Bak/Bax expression did not affect 
C12’s effect to depolarize ∆mito (Figures 3.9D-E) and release cytochrome c 
(Figure 3.11), indicating Bak/Bax are not involved in C12- induced MOMP in 
tumor cells. These results demonstrate that C12-induced apoptotic signaling is 


















Figure 3.9.  C12-induced tumor cell apoptosis is independent of Bak and Bax. 
(A) Bak and Bax expression in the indicated HCT116 cells was examined by 
western blot. (B-C) C12 induced similar levels of cell death (B) and caspase-3/7 
activation (C) among WT, Bak-KO, Bax-KO and Bak/Bax-DKO HCT116 cells after 
24 hours treatment. (D) The mitochondrial potential of the WT and Bak/Bax-DKO 
HCT116 cells loaded with JC1 was determined by fluorescent microscopy upon 
the treatment with 50 M C12 and 5 M FCCP.  Representative results are shown. 
(E) Summary of the data shown in (D). All data are presented as mean ± standard 


























Figure 3.10. Etoposide induces tumor cell death and inhibits xenografted tumor 
growth dependent of Bak and Bax. 
(A) Etoposide induced significant cell death in WT, Bak-KO and Bax-KO HCT116 
cells but not in their Bak/Bax-DKO counterparts after 48 hours of treatment. (B) 
Caspase-3/7 activities were examined 24 hours after etoposide exposure.  All the 
data are presented as mean ± standard deviation of three different experiments. 
Asterisk indicates P < 0.05 (*) or P< 0.01 (**) by student’s unpaired t test. (C-D) 
Growth of HCT116-WT tumors (C) and HCT116-Bak/Bax-DKO tumors (D) in 
athymic nude mice treated with the vehicle control or etoposide.  Data are mean ± 






















Figure 3.11.  C12 triggered cytochrome c release in tumor cells independent of 
Bak and Bax. 
(A-B) Cytochrome c was released from mitochondria in both HCT116-WT (A) and 
HCT116-Bax/Bak-DKO (B) cells upon treating with 100 µM C12 of 3 hours. Typical 
confocal images are shown.  Cytochrome c is shown in red, and DAPI is shown in 


















3.3.7. The inhibitory effects of C12 on tumor growth are independent of Bak and 
Bax. 
To further investigate whether the Bax/Bak-independent effect of C12 to trigger 
apoptosis in vitro also occurred in vivo, WT and Bax/Bak-DKO HCT116 cells were 
inoculated into athymic nude mice. C12 reduced the growth of established 
HCT116-WT tumors and HCT116-Bak/Bax-DKO tumors to a similar degree 
(Figures 3.12A-B), indicating that Bak and Bax are not involved in anti-tumor 
activity of C12. Moreover, the level of activated caspase-3 and the percentage of 
TUNEL-positive cells were higher in C12-treated tumors than vehicle-treated 
tumors regardless of Bak and Bax expression levels (Figures 3.12C-F), suggesting 


















Figure 3.12. C12 inhibits xenografted tumor growth independent of Bak and Bax. 
(A-B) Growth of HCT116-WT tumors (A) and HCT116-Bak/Bax-DKO tumors (B) in 
athymic nude mice treated with vehicle control or C12 (15 mg/kg/day). Data are 
mean ± standard deviation of tumor volumes of 8 animals in each group. (C) 
Apoptotic cells in tumor sections were detected by immunofluorescence staining of 
activated caspase-3. Representative images of tumor sections from DMSO- and 
C12-treated mice are shown. Scale bar, 50 µm. (D) The percentage of activated 
caspase-3 shown in (C) were quantified. Data are mean ± standard deviation of 
three independent tumor sections. Asterisk indicates P< 0.05 (*) or P< 0.01 (**) by 
student's unpaired t test  (E) Typical TUNEL labeling images of tumor sections 
from vehicle control- and C12-treated mice are shown. Scale bar, 60 µm. (F) The 
percentage of TUNEL-positive cells in tumors of C12-treated mice is higher than 
that of control mice. All data are mean ± standard deviation of three independent 
tumor sections. Asterisk indicates P < 0.05 (*) or P< 0.01 (**) by student’s 









3.3.8.  BH-3 only proteins Noxa and Puma are not involved in C12-induced tumor 
cell apoptosis. 
BH3-only proteins are another class pro-apoptotic Bcl-2 proteins, which share 
sequence homology only in the BH3 domain, including Noxa and Puma (149). To 
further elucidate whether BH3-only proteins are involved in C12 cytotoxicity in 
tumor cells, we investigated two HCT116 cell lines in which Noxa expression was 
stably reduced by shRNA (Figure 3.13A) or Puma expression was eliminated 
genetically (Figure 3.13E) (150, 151). C12 caused similar levels of cell death and 
caspase-3/7 activation in HCT116 cell lines with reduced expression of Noxa or 
Puma compared with their corresponding counterparts expressing normal levels of 
Noxa or Puma (Figures 3.13B, 3.13D and 3.13F-G). In contrast, less cisplatin-
induced cytotoxicity was observed in HCT116 cells with decreased Noxa or Puma 
expression (Figures 3.13C and 3.13F-G). Overall, our results suggest that BH3-











Figure 3.13. C12-induced tumor cell apoptosis is independent of BH-3 only 
proteins Noxa and Puma.   
(A) Noxa expression was stably reduced in HCT116 cells by shRNA.  (B) 
Following 24 hours treatment of C12, similar levels of cell death were detected in 
HCT116 cells expressing Noxa shRNA and their control counterparts. (C) Less 
apoptosis was detected in HCT116 cells with reduced Noxa expression upon 
treatment of cisplatin (50 mM). (D) Caspase-3/7activities were measured after 24 
hour-incubation of C12 or cisplatin in the indicated HCT116 cells. (E) Puma 
expression in the indicated HCT116 cells was examined by western blot. (F) Cell 
death was measured after 24 hour-incubation of C12 or tunicamycin in Puma-
deficient HCT116 cells or wild-type cells. (G) Caspase-3/7 activities were 
examined 24 hours after C12 or etoposide exposure. All data are presented as 
mean ± standard deviation of three different experiments. Asterisk indicates P < 
0.05 (*) or P< 0.01 (**) by student’s unpaired t test. ns, no significant. 
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DISCUSSION 
Despite growing evidence that the bacterial quorum-sensing molecule C12 
induces apoptosis in various types of human tumor cells (66, 69-71), the 
relevance of C12 cytotoxicity to tumor growth in animals was unknown. 
Importantly, knowledge about the mechanism of C12-evoked tumor cell 
apoptosis has been limited. Here, we present the evidence that C12 
preferentially triggers transformed cell apoptosis in vitro and inhibits transplanted 
tumor growth in vivo as a single agent independent of both anti- and pro-
apoptotic Bcl-2 proteins. Furthermore, selective cytotoxicity of C12 on lung tumor 
cells and its inhibitory effects on tumor growth are likely related to upregulated 
PON2 expression in the tumor cells. 
 
Many neoplastic cells show an increased ratio of anti-apoptotic to pro-apoptotic 
Bcl-2 proteins, which enables them to survive even under the conditions that 
would normally initiate apoptotic signaling (121, 152). An emerging strategy for 
cancer therapy is to overcome the resistance to apoptosis caused by aberrant 
Bcl-2 signaling in tumor cells (153). Recently, several small molecules triggering 
apoptosis independent of either pro- or anti-apoptotic Bcl-2 proteins have been 
identified as potential anti-tumor drugs. Among them, the pentacyclic triterpenoid 
betulinic acid induces Bax/Bak-independent MOMP and subsequent apoptosis 
(154). Unlike C12, cytotoxic effects of betulinic acid are influenced by Bcl-2 
overexpression and it is ineffective against epithelial tumors. Similarly, Bax/Bak is 
also nonessential in apoptotic signaling induced by chelerythrine (155), 
mitochondrial Kv1.3 channels inhibitors (156) or titanium dioxide (TiO2) (157). 
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The polyphenolic compound gossypol evokes Bax/Bak-independent apoptosis 
and inhibits Bcl-2-overexpressing tumor growth (158). Furthermore, Bcl-2 
expression fails to influence human tumor cell apoptosis induced by the antibiotic 
agent Tetrocarcin-A or protein complex HAMLET (128, 129). Compared with 
those molecules, C12 is the first small molecule compound, to the best of our 
knowledge, inducing human tumor cell apoptosis in vitro as well as blocking 
tumor growth in vivo independent of both pro- and anti-apoptotic Bcl-2 proteins.  
  
The apoptosis cascade induced by C12 in tumor cells is unique, evident by its 
rapid pro-apoptotic effects, such as depolarizing mitochondrial membrane 
potential within minutes (Figures 3.4 and 3.9), releasing cytochrome c into the 
cytosol within three hours (Figures 3.7 and 3.11) and maximally activating 
caspases within four hours (Figure 3.1). These distinctive pro-apoptotic features 
of C12 have not been observed in any other apoptosis paradigms of cancer cells, 
which might be attributed to the ability of C12 or its derivatives generated in 
tumor cells to directly permeabilize mitochondria (within minutes) without the 
involvement of pro- and anti-apoptotic Bcl-2 proteins.  
 
As Pseudomonas aeruginosa produces C12 to control virulence factors, C12 
alone could potentially promote infections, particularly in immune compromised 
patients (159). Published information about the safety of C12 in vivo is limited 
except that C12 exerts acute influence in immune responses in mice. For 
instance, C12 reduces innate immune responses acutely via disrupting TLR4-
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dependent NF-B signaling in mice (62). In a murine model of dermal 
inflammation, intradermal injection of C12-loaded micelles leads to local immune 
cell infiltration within 24 hours (63). In our studies, administration of C12 for 
extended periods of time does not appear to cause significant toxicity to either 
normal or immunodeficient athymic nude mice (Figure 3.2), suggesting that long-
term side effects of administrating C12 on animals might be limited. 
 
Overall, our study reveals that C12 inhibits tumor growth in animals as a single 
agent, through inducing a unique Bcl-2 protein-independent apoptotic cascade in 
tumors. Therefore, C12 is an ideal candidate of a lead compound for novel 










PARAOXONASE 2 IS ESSENTIAL FOR THE PROLIFERATION OF 
NON-SMALL CELL LUNG CANCER CELL 
4.1  INTRODUCTION 
Human cancer originates from abnormal accumulation of a clonal population of 
somatic cells, which disrupts tissue homeostasis (121, 160).  The initiation and 
progression of cancer involves genetic changes resulting in alterations in tissue 
development and homeostatic maintenance.  Understanding how genetic 
alterations regulate tumor cell proliferation is essential for successful prevention, 
diagnosis and treatment of tumors.   
 
Among the genes whose expression is altered in tumor cells is an enzyme 
named paraoxonase 2 (PON2) (78, 79, 161-164). PON2 belongs to a highly 
conserved gene family (PON1, 2, 3) with lactonase and arylesterase activities 
(165-167).  The three PON (1-3) genes are located in a cluster on human 
chromosome 7 or mouse chromosome 6, and PON proteins share about 66% of 
identity in amino acid sequences (168, 169).  PON1 is secreted out of cells and 
associated with high-density lipid protein (HDL) in the blood   following secretion 
(170).  Like PON1, PON3 is also bound to HDL in the blood stream (171).  In 
contrast, PON2 is an intracellular enzyme (172).  PON1 and PON3 are primarily 
found in the liver, whereas PON2 is ubiquitously expressed in a number of 
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tissues, including the liver, kidney, lung, heart, stomach, spleen, pancreas and 
macrophages (173).  The three PON proteins possess overlapping but distinct 
enzymatic specificity (76, 174, 175).  Among various substrates of PON proteins, 
N-acyl-homoserine lactones are of special interest, since they are quorum-
sensing molecules for communication among pathogenic bacteria (59, 84, 176).  
Growing evidence demonstrate that PON proteins, particularly PON2, modulate 
many biological effects of N-acyl-homoserine lactones, such as triggering stress 
signaling and apoptosis in host cells (74, 95, 177, 178).  The hydrolysis of N-acyl-
homoserine lactones by PON2 is expected to reduce quorum sensing by the 
bacteria and subsequently alleviate responses of host cells to N-acyl-homoserine 
lactones. 
 
In addition to its lactonase-esterase activity, PON2 also displays antioxidant 
activity (72). The antioxidant activity may contribute to the ability of PON2 to 
possess both anti-inflammatory and anti-apoptotic functions (72, 175) as well as 
explain why PON2 is often upregulated in cancer (78, 79, 161-164).  Normally 
PON2 mutations that reduce its lactonase activity do not alter its antioxidant 
activities, demonstrating that these two functions are mediated by different 
aspects of PON2.  However, the role of PON2 lactonase activity in mediating 
apoptosis appears to be determined by the particular apoptosis signaling 
pathways involved (138, 179).  For instance, PON2 mutants lacking lactonase 
activity seems to be more effective in preventing apoptosis in the Bax/Bak-
dependent canonical apoptotic signaling pathway than wild type PON2 (179).  In 
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contrast, PON2 uses its lactonase activity to promote a unique Bax/Bak-
independent apoptosis in response to a homoserine lactone (138). 
 
4.2  MATERIALS and METHODS 
4.2.1.  Reagents 
N-(3-oxododecanoyl)-homoserine lactone (C12) and polybrene were acquired 
from Sigma (St. Louis, MO). Propidium iodide (PI) was purchased from Invitrogen 
(Carlsbad, CA).  All reagents were dissolved in Dimethyl sulfoxide (DMSO).  
Lipofectamine 2000® was obtained from Invitrogen.   Antibodies (Ab) used for 
western blot analysis were anti-β-actin mAb (Sigma), anti-human PON2 (Abcam; 
Cambridge, MA), anti-mouse PON2 pAb (antibodies-online; Atlanta, GA), anti-
SDHA mAb (Cell signaling; Danvers, MA), peroxidase-conjugated goat anti-rabbit 
IgG (Thermo; Waltham, MA), peroxidase-conjugated goat anti-mouse IgG 
(Thermo), peroxidase-conjugated mouse anti-rabbit IgG (TrueBlot®, Rockland; 
Limerick, PA), peroxidase-conjugated rat anti-mouse IgG (TrueBlot®, Rockland). 
 
4.2.2.  DNA plasmids 
Murine PON2 cDNA was purchased from Origene (Rockville, MD) and 
subsequently cloned into the lentiviral expression vector pCDH-CMV-MCS-EF1-
copGFP (System Biosciences; Palo Alto, CA) to generate the plasmid  pCDH-
CMV-mPON2-EF1-copGFP with the green fluorescent protein (GFP) functioning 
as an indicator of infection.  The identity of the plasmids was validated by 
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sequencing.  Lentiviral shRNA plasmid for human PON2 and its counterpart with 
scramble sequence were purchased from Santa Cruz (Dallas, TX). 
 
4.2.3.  Retrovirus and lentivirus production  
For lentivirus production, the package cell line human embryonic kidney (HEK)-
293T was transfected with the plasmid pCDH-CMV-mPON2-EF1-copGFP, 
human PON2 shRNA plasmid or their corresponding control plasmids along with 
the helper plasmids pMDLg/pRRE, pRSV.Rev, and pMDG2.0 (Addgene; 
Cambridge, MA) using the Lipofectamine 2000 ® transfection reagent.   Medium 
containing lentivirus was collected 48-72 hours following transfection.  
 
4.2.4.  Generation of cell lines and cell culture 
Non small cell lung carcinoma cell lines A549 and NCI-H1299 were purchased 
from ATCC (Bethesda, MD).  HEK293T cells were also obtained from ATCC.  
Human bronchial epithelial (HBE) cells immortalized by expressing hTERT and 
Cdk4 were acquired from Professor Geoffrey Clark (University of Louisville).  To 
generate cells with reduced PON2 expression or empty vector control, A549, 
NCI-H1299, HEK293T and HBE cells were infected with the medium containing 
corresponding lentivirus and 10 µg/ml of polybrene to enhance infection 
efficiency.  Stable cell lines were generated by culturing cells in the medium 
containing 2 g/ml puromycin.  A549 and NCI-H1299 cells expressing murine 
PON2 were generated by infection with the lentiviral supernatants containing 10 
µg/ml of polybrene.  Almost all of the infected cells (>95%) were GFP positive as 
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evaluated by flow cytometry (FACScalibur, Beckon Dickinson; San Jose, CA).  
All of cell lines were cultured  in Dulbecco's Modified Eagle Medium (DMEM) 
medium (Mediatech; Manassas, VA) supplemented with 10 % fetal bovine serum 
(FBS) (Gemini; West Sacramento, CA), 100 U/ml penicillin (Mediatech), and100 
µg/ml streptomycin (Mediatech) in an incubator with 95 % humidity and 5 % CO2 
at 37oC.  
 
4.2.5.  Cell viability assay  
The indicated cells were cultured in 48-well tissue culture plates with 1x104 cells 
in each well 24 hours before treatment with apoptotic stimuli.  At the indicated 
time points following the treatment, cells were trypsinized and resuspended in 
growth medium containing 1 µg/ml propidium iodide.  Cell viability was evaluated 
by a PI exclusion approach using flow cytometry (FACScalibur).  The 
experiments were performed in triplicates.  The percentage of cell death is 
calculated as 100 minus the percentage of viable cells. . 
 
4.2.6.  Cell cycle analysis and cell proliferation assay 
For cell cycle analysis, 5 × 105 cells were sedimented (300 x g for 5 minutes) and 
washed twice with 500 µl 1 x PBS.  Cells were then fixed with 1 ml 70% ethanol 
in 1 x PBS at 4oC overnight.  After centrifugation (300 x g for 5 minutes), cells 
were washed twice with 1 x PBS and resuspended in 500 µl 1 x PBS.  50 U 
RNase A (Qiagen; Valencia, CA) were added to samples followed by incubation 
at 37oC for 1 hour.  Then propidium iodide (5 µg) was added to samples which 
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were incubated for 30 minutes at 37oC before flow cytometric analysis 
(FACScalibur).  To evaluate cell proliferation, 1.5 × 104 cells were plated in wells 
of a 12-well tissue culture plate and the number of the cells in each well was 
determined using a hemocytometer. 
 
4.2.7.  Western blot analysis 
Cell pellets were collected, and whole cell lysates were generated by 
resuspending cells in RIPA lysis buffer (150 mM sodium chloride, 1% (v/v) Triton 
X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, and 50 mM 
Tris, pH 8.0) containing protease inhibitors (Complete, Roche; Indianapolis, IN).  
To remove cell debris and nuclear materials, cells were first sonicated for 30 
seconds at 10% amplitude (Sonic Dismembrator, Model 500, Fischer Scientific; 
Hampton, NH) before centrifugation at 13,000 x rpm at 4oC for 10 minutes, and 
the supernatant was collected. The protein concentration was determined using 
the BCA Assay (Pierce; Rockford, IL). Thirty micrograms of protein sample were 
loaded on a 4-12% Bis-Tris gel (Bio-Rad; Hercules, CA) and transferred to PVDF 
(Millipore; Billerica, MA).  The membrane filters were incubated in buffer 
containing 1 x PBS, 0.2% (v/v) Tween 20, and 10% (w/v) nonfat dry milk 
(BioRad) with appropriate primary antibodies at 4oC overnight or at 25oC for 
about three hours.  After three 10 minute wash with 1 x PBS/0.2% Tween 
solution, the membrane filters were then incubated with the appropriate 
peroxidase-coupled secondary antibodies at 4oC overnight or for at 25oC for 
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three hours.  Proteins were detected using the enhanced chemiluminescent 
detection system (Thermo). 
 
4.2.8.  Lung tumor tissues from patients 
Tumor tissues along with corresponding adjacent normal tissues from non small 
cell lung carcinoma (NSCLC) patients were acquired from the James Graham 
Brown Cancer Center Bio-Repository at University of Louisville following an 
approved IRB protocol. Frozen tissue samples were resuspended in tissue 
protein extraction reagent (Thermo Fisher) supplemented with protease inhibitors 
(Complete, Roche; Indianapolis, IN) and phosphatase inhibitors (PhosSTOP, 
Roche). Following homogenization and centrifugation, protein concentration was 
determined by BCA assay (Thermo Fisher). Thirty micrograms of total protein 
were electrophoresed in 4–12% Bis/Tris gels (Bio-Rad; Hercules, CA). PON2 
was detected by western blot. 
 
4.2.9.  Immunoprecipitation 
A549 cells (1 x 108) were collected and washed once with 1 x PBS.  Cells were 
resuspended in cell lysis buffer containing 12 mM HEPES (pH 7.5), 1.7 mM Tris-
HCl (pH 7.5), 100 mM KCl, 140 mM mannitol, 23 mM sucrose, 2 mM KH2PO4, 1 
mM MgCl2, 0.67 mM EGTA, and 0.6 mM EDTA supplemented with protease 
inhibitors (Complete; Roche Diagnostics, Indianapolis, IN).  The cells were 
broken open by a dounce homogenizer.   The whole cell lysate was centrifuged 
at 300 x g for 10 minutes at 4oC to remove large cellular debris and nuclei.   The 
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remaining supernatant was centrifuged at 10,000 x g for 10 minutes at 4˚C, and 
the resulting mitochondria-enriched pellet was resuspended in mitochondrial lysis 
buffer containing 50 mM Tris (pH7.5), 150 mM NaCl, 0.05% SDS, 1% NP-40 and 
protease inhibitors.  The mitochondrial lysate was acquired by passing through a 
syringe with a needle (Gauge 30) 10 times to break open mitochondria.  
Following centrifuged at 16,000 x g for 10 minutes at 4oC, the protein 
concentration of the supernatant was determined by a BCA assay.  Mitochondrial 
lysate (4 mg) was incubated with 20 l anti-Rabbit Ig IP agarose beads (50% 
slurry, TrueBlot®, Rockland; Limerick, PA) at 4oC for 30 minutes to preclear 
nonspecific protein interaction.  Precleared mitochondrial lysate was split into two 
equal parts.  One part was untouched and the other part was incubated with 5 l 
anti-PON2 antibodies (Abcam) overnight at 4°C. Then anti-Rabbit Ig IP agarose 
beads (50 μl of 50% bead slurry) were added to the mixture of protein lysate and 
antibodies and incubated with gentle rocking for 3 hours at 4°C. Following 
centrifugation at 16,000 x g for 2 minutes at 4oC, the beads were washed 3 times 
with 500 μl of mitochondrial lysis buffer.  The beads with bound proteins were 
sent to the Genome Center at University of California, Davis for proteomic 
analysis. 
 
4.2.10.  Proteome data analysis 
The resulting. msf files from Proteome Discoverer were loaded into Scaffold Q+S 
v4.3.2. Scaffold was used to calculate the false discovery rate using the peptide 
and protein prophet algorithms. The results were annotated with mouse gene 
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ontology information from the Gene Ontology Annotations Database. Heat maps 
were compiled in the open-source statistical programming language R. Proteome 
output as Log2 fold change of control was analyzed with the heatmap.2 function 
of the gplots package, using the methods described by Key et al. Pearson’s 
correlation coefficient was used to measure distance, and the Ward method 
(ward.D) was the agglomeration method for row and column clustering. 
 
4.2.11.  Statistical analysis 
Statistical analysis was performed using the student t-test and the two way 















4.3  RESULTS 
4.3.1. PON2 expression is enhanced in human lung tumor tissues and 
oncogenically transformed HBE cells. 
 
It has been shown that PON2 upregulation in some cancer cells, including lung 
cancer cell lines, enables cancer cells to become resistant to conventional 
therapeutic drugs (79). To determine whether PON2 expression is enhanced in 
human lung cancer, we examined PON2 protein levels in tumor tissues of non-
small cell lung carcinoma (NSCLC) patients by western blot. Among eleven 
samples from patients, we found that PON2 was overexpressed in eight of lung 
cancer tissues compared with corresponding adjacent normal tissues, whereas 
its expression was slightly decreased in three of them (Figure 4.1A).  As Ras-
transformed HBE displayed higher levels of apoptosis compared with their 
untransformed counterparts upon C12 treatment (Figures 3.1A-B), PON2 
expression was also increased in transformed HBE cells (Figure 4.1C).  These 
observations provide more evidence that oncogenic transformation enhances 















Figure 4.1. PON2 expression is enhanced in human lung tumor tissues and 
oncogenically transformed HBE cells. (A) Expression of PON2 in NSCLC 
tissue specimens and corresponding adjacent normal tissues from 11 patients 
were evaluated by western blot. Samples 1-4, 6, 8, 9, 11 were from 
adenocarcinoma patients, whereas samples 5, 7, 10 were from squamous cell 
carcinoma patients. T, tumor; N, normal. (B) The intensities of bands in (A) 
were quantified using ImageJ software (NIH). To normalize loading variation, 
the relative levels of PON2 were calculated by dividing the PON2 value into the 
corresponding value for actin. The data were shown as a ratio of PON2 levels 
in a tumor tissue sample versus its corresponding normal tissue, and the value 
bigger than 1 indicates that PON2 expression is increased in tumor tissues. 
Differential expression of PON2 in tumor versus normal tissues is significant 
with the value of “P” smaller than 0.01 as calculated by student’s paired t test. 
(C) The expression of PON2 and PON3 in primary HBE cells and their 









4.3.2. PON2 blocks chemotherapeutic drug-triggered apoptosis in NSCLC 
cells.  
To examine the role of PON2 in NSCLC cells’ apoptotic responses, we 
investigated the prospective involvement of endogenous PON2 in cytotoxicity of 
chemotherapeutic drugs.  We employed shRNA to stably reduce PON2 
expression in human NSCLC cell lines A549 and NCI-H1299, and endogenous 
PON2 levels were markedly decreased (Figures 4.2A and 4.2D).  Increased cell 
death and caspase-3/7 activation observed in PON2-deficient cells in response 
to the conventional apoptotic stimuli actinomycin D (Figures 4.2B-4.2E-F).  This 
is in agreement with previous studies, and the anti-apoptotic effects of PON2 is 










Figure 4.2. PON2 blocks chemotherapeutic drug-triggered apoptosis.  
(A) PON2 expression in A549 cells was stably reduced by shRNA, and PON2 
expression was determined by western blot. (B) The viability of A549 was 
measured 32 hours after ActD treatment.  (C) ActD induced less cell death in 
A549 cells with reduced PON2 expression than control vector cells 48 hours 
after treatment.  (D) Stable reduction of PON2 expression in NCI-H1299 cells 
was evaluated by western blot. (E) NCI-H1299 cell viability was assessed 24 
hours following ActD exposure.  (F) Less apoptosis was detected in NCI-H1299 
cells with reduced PON2 expression upon ActD treatment for 24 hours.  “ActD”; 
actinomycin D.  All data shown are mean ± standard deviation of three 
independent experiments.  Asterisks indicate P values of ˂ 0.05 (*) by 














4.3.3. PON2 is required in C12 cytotoxicity in human NSCLC cells.  
Overexpression of PON2 promotes cytotoxicity of C12 in non-transformed MEF 
and HEK293T cells (138), but the role of endogenous PON2 in C12-induced 
apoptotic signaling is unclear.  To further explore the mechanism of C12-
triggered apoptosis, we investigated the prospective involvement of endogenous 
PON2 in C12 cytotoxicity in NSCLC cells.  Treatment with C12 elicited less cell 
death and caspase-3/7 activation in A549 and NCI-H1299 cells lacking PON2 
expression (Figure 4.3). The distinct roles of PON2 in apoptosis of NSCLC cells 
induced by C12 and therapeutic drugs provide more evidence that a novel form 













Figure 4.3. PON2 is required in C12’s cytotoxicity on NSCLC cells  
(A) C12 induced less cell death in A549 cells with reduced PON2 expression 
than control vector cells 32 hours after treatment. (B) Upon treatment with 
different doses of C12 for 32 hours, less caspase-3/7 activation was detected 
in cells with reduced PON2 expression.  (C) C12 induced less cell death in 
NCI-H1299 cells with reduced PON2 following 24-hour treatment. (D) Less 
apoptosis was detected in NCI-H1299 cells with reduced PON2 expression 
upon C12 treatment.  All data shown are mean ± standard deviation of three 
independent experiments.  Asterisks indicate P values of ˂ 0.05 (*) or ˂ 0.01 















4.3.4. Murine PON2 sensitizes human lung tumor cells with reduced 
endogenous PON2 expression to C12. 
To validate the role of PON2 in mediating C12-induced apoptosis, we stably 
overexpressed murine PON2 cDNA in A549 cells deficient in PON2 expression 
by retroviral infection (Figure 4.4A).  Upon treatment with C12, we observed 
more cell death and caspase-3/7 activation in PON2-deficient A549 cells 
overexpressing murine PON2 compared to vector control and parental cells 
(Figure 4.4B).  Similarly, stable overexpression of murine PON3 in PON2-
knockdown NCI-H1299 cells was confirmed by western blot (Figure 4.4C). We 
found that C12 induced more cell death and elicited higher caspase-3/7 



















Figure 4.4. Murine PON2 sensitizes human lung tumor cells with reduced endogenous 
PON2 expression to C12. (A) Murine PON2 cDNA was stably overexpressed in A549 
cells with reduced PON2 expression by retroviral infection. Expression levels of PON2 
were determined by western blot. (B) After treating with different doses of C12 for 24 
hours, more cell death were detected in PON2-knockdown A549 cells with increased 
mouse PON2 expression comparing to vector control and parental cells. (C) Stable 
overexpression of murine PON3 in PON2-knockdown NCI-H1299 cells was examined 
by western blot. (D) C12 induced more cell death in PON2-knockdown NCI-H1299 
cells expressing mouse PON2 after 24 hours treatment.  All data shown are mean ± 
standard deviation of three independent experiments.  Asterisks indicate P values of ˂ 














4.3.5. PON2 is essential for C12-triggered cell death in HEK-293T and HBE 
cells. 
To further explore the involvement of PON2 in apoptotic signaling in non-
transformed cells, endogenous PON2 expression was stably reduced in 
Human Embryonic Kidney-293T (HEK-293T) cells, whose viability was 
assessed upon treatment with C12 (Figures 4.5A-B). Reducing PON2 
expression in HEK-293 cells enabled cells resistant to C12.  Furthermore, we 
stably decreased PON2 expression in immortalized human bronchial epithelial 
(HBE) cells (180) and measured cell viability upon C12 exposure (Figures 
4.5C-D).  Reducing PON2 expression in HBE cells de-sensitized cells to C12.  
Overall, these data provide evidence that PON2 plays a similar role in 













Figure 4.5. PON2 is essential for C12-triggered cell death in HEK-293T and 
HBE cells. (A) PON2 expression was stably reduced in HEK-293Tcells.  (B) 
The viability of HEK-293Tcells was measured 24 hours after C12 treatment.  
(C) Stable decrease of PON2 expression in human bronchial epithelial (HBE) 
cells was determined by western blot. (D)The viability of HBE was evaluated 24 
hours following C12 exposure.  Mean ± standard deviation for three 
independent experiments are shown. For all the data, *, P < 0.05, Student’s 

















4.3.6. PON2 is essential for human lung tumor cell proliferation but not  non-
transformed cell proliferation. 
During the process of generating A549 and NCI-H1299 cells lacking PON2 
expression, we observed that those cells proliferated much slower than their 
vector control counterparts.  To determine whether or not PON2 is essential for 
human lung tumor cell proliferation, we measured the proliferation of A549 cells 
and NCI-H1299 expressing PON2 shRNA or the empty vector control. We 
found that proliferation of NCI-H1299 and A549 cells with reduced PON2 
expression was slower compared to that of their empty vector expressing 
counterparts (Figure 4.6A-B), implicating a role of PON2 in lung tumor cell 
proliferation.  To determine whether or not PON2 is involved in the proliferation 
of non-transformed cells, we measured the proliferation of HEK-293T and HBE 
expressing PON2 shRNA or the empty vector control.  It was found that HEK-
293T and HBE cells lacking PON2 expression grew at the same rate as their 
counterparts expressing the empty vector (Figure 4.6C-D), indicating that 
PON2 is not involved in non-transformed cell proliferation.  Overall, these data 
indicate that PON2 mediates apoptosis independently of its function to 





















Figure 4.6. PON2 is essential for human lung tumor cell proliferation but not 
non-transformed cell proliferation.  The proliferation of A549 cells (A), NCI-
H1299 cells (B), HEK-293T cells (C) and HBE cells (D) expressing PON2 
shRNA or the empty vector control was measured.  Proliferation of NCI-H1299 
and A549 cells with reduced PON2 expression was slower compared with their 
counterparts expressing the empty vector.  HEK-293T cells (C) and HBE cells 
with reduced PON2 expression proliferated at the same rate as their vector 
control counterparts.  All data shown are mean ± standard deviation of three 
independent experiments.  Asterisks indicate P values of ˂ 0.05 (*) by 














4.3.7. Deficiency in PON2 expression induces G1 cell cycle arrest of A549 
cells. 
To investigate the effects of deficient PON2 expression, we performed cell 
cycle analysis to determine the cell cycle profile of A549 cells expressing 
PON2 shRNA or the empty vector. We found that deficiency in PON2 





















Figure 4.7. Deficiency in PON2 expression induces G1 cell cycle arrest of A549 
cells. (A) Cell cycle profiles of A549 cells expressing PON2 shRNA or the 
empty vector control were determined.  (B) Summary of the data shown in (A).  
Reducing PON2 expression caused higher percentage of the cells in G1 phase 
of cell cycle.  All data shown are mean ± standard deviation of three 
independent experiments.  Asterisks indicate P values of ˂ 0.01 (**) by 





4.3.8. PON2 interacts with components of mitochondrial electron transport chain. 
Since PON2 is known to be localized on mitochondrial inner membrane and 
probably cleave oxidized mitochondrial lipids (73, 181), we carried out a 
proteomics study to identify mitochondrial proteins associated with PON2 (Figure 
4.8A).  Mitochondria were isolated from A549 cells by a biochemical fractionation 
approach, and proteins bound to PON2 were acquired by immunoprecipitation 
using antibodies against PON2.  Twelve mitochondrial proteins were discovered 
in protein complexes containing PON2, and several potential PON2-binding 
proteins are components of mitochondrial electron transport chain.  Among them, 
a component of Complex II, succinate dehydrogenase complex flavoprotein 
subunit A (SDHA), displayed highest specific binding to PON2 (Figure 4.8B-C).  
These data suggest that PON2 interacts with components of mitochondrial 














Figure 4.8. PON2 interacts with components of mitochondrial electron transport 
chain.  (A) The depiction of immunoprecipitation study to identify mitochondrial 
proteins associated with PON2.  (B) Twelve mitochondrial proteins were found in 
protein complexes containing PON2.  (C) Relative abundance of PON2 and 
SDHA was evaluated by calculating normalized total TIC in a proteomics study.  



















4.4  DISCUSSION 
Despite recent progress, the detailed mechanisms underlying the initiation and 
development of non-small NSCLC are still missing.  Understanding of these 
mechanisms is essential for successful prevention, diagnosis and treatment of 
NSCLC.  Here we report that PON2 is overexpressed in tumor tissues of NSCLC 
patients compared with corresponding adjacent normal tissues.  Importantly, 
enhanced PON2 expression in NSCLC cells is essential for their proliferation, as 
reducing PON2 expression in NSCLC cells results in cell cycle arrest at the G1 
phase and markedly slower proliferation.  It is conceivable that enhanced PON2 
expression in NSCLC cells sustain rapid cell proliferation, probably by influencing 
mitochondrial bioenergetics.  Previous research of PON2 expression in tumor 
cells largely focuses on its effects on conferring resistance to chemotherapeutic 
drugs (78, 79, 95).  Our data for the first time demonstrate a critical role of PON2 
in NSCLC cell proliferation. 
 
As a lactonase/arylesterase with anti-oxidant properties, PON2 expression is 
elevated under a variety of physiological and pathological conditions.  In mouse 
peritoneal macrophages, oxidative stress promotes PON2 expression at both 
mRNA and protein levels, but decreases PON3 expression (182).  Similarly, 
enhanced reactive oxygen species (ROS) production in vascular cells evokes 
oxidative stress, which in turn elevates PON2 expression (183).  During 
monocytes differentiation into macrophages, PON2 expression is increased 
through a mechanism dependent on activating nicotinamide-adenine-
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dinucleotide-phosphate (NADPH)-oxidase, which is partially modulated by the 
transcription factor AP-1 (184).  A common theme arisen from these studies is 
that PON2 expression increase may represent a compensatory signaling 
cascade against the enhanced cellular oxidative stress,  which is in agreement 
with the well-established anti-oxidative activity of PON2 (73, 78, 179, 181, 183, 
185). 
 
The level of oxidative stress within cells greatly influences many important 
cellular functions of mammalian cells (186).  Emerging evidence supports the 
idea that a persistent and excessive production of intracellular ROS is involved in 
the initiation and progression of cancer (187-189).  ROS function as cellular 
messengers in signaling cascades of cancer cells to initiate tumorigenesis and 
promote tumor development, consistent with their activity to evoke DNA damage 
and subsequent tumorigenic genetic mutations.  Therefore, it is conceivable that 
PON2 expression may be elevated in cancer cells with high levels of oxidative 
stress to provide protection against ROS-induced damages.  Indeed, enhanced 
PON2 mRNA levels have been observed in a variety of tumors through 
microarray studies (161-164).  Subsequent experiments using tumor samples 
combined from patients or healthy people further validate the increased PON2 
expression at the protein levels in some of those tumors (78).  In this study, we 
directly compare PON2 expression at protein level in human NSCLC tumor 
tissues with neighboring normal tissues from the same patient (Figure 4.1).  Our 
data provide unequivocal evidence that PON2 are overexpressed in NSCLC, 
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which is critical for NSCLC cell proliferation but not for their untransformed 
counterparts (Figure 4.6).  Although the signaling pathway utilized by NSCLC 
cells to achieve an increase in PON2 expression is still unclear, the underlying 
mechanisms is likely associated with elevated oxidative stress in cancer cells. 
 
Rapidly proliferating tumor cells is known to consume high levels of glucose and 
produce lactate as major glucose-derived carbon in the presence of oxygen 
(termed the Warburg effect), which was originally thought to be caused by 
irreversible damages to mitochondrial oxidative metabolism and a subsequent 
compensatory increase in glycolysis (190).  However, many highly proliferating 
tumor cells do not exhibit dysfunction in mitochondrial oxidative metabolism after 
careful studies (191, 192).  Furthermore, oncogenic transformation of human 
mesenchymal stem cells promotes mitochondrial bioenergetics (193), and 
mitochondrial metabolism is essential for Kras-evoked tumor cell proliferation and 
tumorigenesis (194, 195).  These findings demonstrate a critical role of 
mitochondrial oxidative metabolism in tumor cell proliferation.  The observation of 
reduced electron transport chain activities and oxygen consumption in PON2-
deficient mice provides evidence that PON2 plays a critical role in maintaining 
mitochondrial respiratory chain (73, 196).  Thus, a possible scenario is that 
overexpressed PON2 functions in NSCLC cells to promote mitochondrial 
oxidative metabolism to meet the metabolic demand for rapid proliferation of 
cells. 
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Our proteomics studies demonstrate that PON2 likely interacts with components 
of mitochondrial electron transport chain (Figure 4.8).  Among them, SDHA, a 
component of Complex II, displayed highest specific binding to PON2.  In 
addition, PON2 also interacts with several subunits of the water-soluble catalytic 
sector (F1) of adenosine triphosphate (ATP) (Figure 4.8).  Currently it remains 
unknown which component of electron transport chain functionally interacts with 
PON2, but our study clearly reveals an important function of PON2 in NSCLC cell 
proliferation.  Future studies will focus on elucidating the detailed molecular 
















CONCLUSION AND FUTURE DIRECTIONS 
 
5.1.  Summary and Conclusions 
Pseudomonas aeruginosa produces N-(3-oxododecanoyl)-homoserine lactone 
(C12) as a quorum-sensing molecule for bacteria-bacteria communication. C12 is 
known to influence many aspects of human host cell physiology, including 
induction of cell death. Further to this, C12 has been reported to induce 
apoptosis in various types of tumor cells. However, the detailed molecular 
mechanism of C12-triggerred tumor cell apoptosis remains unclear. Additionally, 
it is completely unknown whether C12 possesses any potential therapeutic 
effects in vivo. To clarify cell death signaling induced by C12, we examined 
mouse embryonic fibroblasts (MEFs) deficient in “initiator” caspases or “effector” 
caspases. Our data has indicated that C12 selectively induces the mitochondria-
dependent intrinsic apoptotic pathway by quickly triggering mitochondrial outer 
membrane permeabilization (MOMP).  Importantly, the activities of C12 to 
permeabilize mitochondria is independent of activation of both “initiator” and 
“effector” caspases.  Furthermore, C12 directly induces MOMP in vitro.   Our 
studies have also indicated that, unlike most apoptotic inducers, C12 evokes a 
novel form of apoptosis in tumor cells independent of both pro- and anti-apoptotic 
Bcl-2 proteins. We have also determined that C12 inhibits tumor
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growth in animals regardless of either pro- or anti-apoptotic Bcl-2 proteins. 
Furthermore, we have demonstrated that unlike conventional chemotherapeutics, 
C12 requires paraoxonase 2 (PON2), a lactonase/arylesterase with anti-oxidant 
properties, to exert its cytotoxicity on tumor cells. Our recent studies have found 
that PON2 is overexpressed in tumor tissues of non-small cell lung cancer 
(NSCLC) patients compared with corresponding adjacent normal tissues. 
Importantly, enhanced PON2 expression in NSCLC cells is essential for their 
proliferation, as reducing PON2 expression in NSCLC cells results in cell cycle 
arrest at the G1 phase and markedly slower proliferation.  In contrast, altering 
PON2 expression fails to influence the proliferation of untransformed human 
epithelial cells, including bronchial epithelial cells.  Using proteomics and 
biochemical approaches, we have shown that PON2 in NSCLC cells specifically 
interacts with succinate dehydrogenase complex flavoprotein subunit A (SDHA), 
a component of Complex II of mitochondrial electron transport chain.  Overall, 
our studies have discovered a mitochondrial apoptotic-signaling pathway 
triggered by C12, in which C12 or its metabolite(s) acts to permeabilize 
mitochondria, leading to activation of apoptosis.  Moreover, our results 
demonstrate that C12 inhibits tumor growth independent of both pro- and anti-
apoptotic Bcl-2 proteins via the induction of unique apoptotic-signaling mediated 
by PON2 in tumor cells. Enhanced PON2 expression in NSCLC cells might 




5.2. Future Perspectives 
We will investigate the mechanism of apoptosis mediated by PON2/C12 
interaction. C12 is preferentially toxic to cells expressing PON2.  PON2 is known 
to function as a lactonase to cleave C12.  We postulate that PON2 hydrolyzes 
C12 in cells, generating a pro-apoptotic molecule to induce Bcl-2 protein-
independent apoptosis.  
 
We will also Investigate the mechanism of PON2 in modulating lung tumor cell 
proliferation.PON2 is overexpressed in tumor tissues from NSCLC patients. 
PON2 expression is important for the proliferation of NSCLC cells but not for their 
untransformed counterparts.  Therefore, we propose that enhanced PON2 
expression in NSCLC cells promotes mitochondrial bioenergetics which 
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APPENDIX: LIST OF ABBREVIATIONS 
5-FU   5-Fluorouracil  
Apaf-1   Apoptotic Protease Factor 1 
BH   Bcl-2 homolog 
C12   N-(3-oxododecanoyl)-homoserine lactone 
COQ10  Coenzyme Q10  
DISC   Death Inducing Signaling Complex 
FADD   Fas Associated Death Domain  
FasL   Fas Ligand 
FBS   Fetal Bovine Serum 
IAPs   Inhibitor of Apoptosis Proteins 
LLC   Lewis Lung Carcinoma 
MEFs   Mouse Embryonic Fibroblasts 
MIPs   Maximum Intensity Projections 
MOMP   Mitochondrial Outer Membrane Permeabilization 
NHBE   Human Bronchi/Tracheal Epithelial Cells 
NSCLC  Non-Small Cell Lung Carcinoma 
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OMM   Outer Mitochondrial Membrane 
PBS   Phosphate Buffered Saline 
PI   Propidium Iodide 
PON2   Paraoxonase 2 
ROIS   Regions of Interest 
TLR4   Toll-Like Receptor 4 
TNF   Tumor Necrosis Factor 
TNFR   Tumor Necrosis Factor Receptor 
TNFR1  Tumor Necrosis Factor Receptor 1 
TRAIL   TNF-Related Apoptosis Inducing Ligand 
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